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ABSTRACT 
Rate of Body Dysmorphic Disorder Among Patients Seeking Facial Cosmetic Procedures 
Canice Ellen Crerand 
David B. Sarwer, Ph.D. and Michael R. Lowe, Ph.D. 
 
 
 
Body dysmorphic disorder (BDD) is defined as a preoccupation with an imagined 
or slight defect in appearance resulting in significant distress or impairment in important 
areas of functioning (APA, 2000).  BDD patients are often concerned with facial features 
and are also likely to present to cosmetic surgery settings for treatment of their perceived 
defect (Phillips & Diaz, 1997).  Studies have reported rates of BDD of 7-12 % in patients 
from cosmetic surgery and dermatology settings (Sarwer, Wadden, Pertschuk, 
&Whitaker, 1998; Phillips, Dufresne, Wilkel, & Vittorio, 2000). Methodological 
weaknesses, including lack of control groups, reliance on surgeons’ judgments of slight 
or minimal deformity, and the use of different measures to assess for BDD, necessitate 
further study of the rate of BDD in patients seeking cosmetic procedures.   
This study was designed to further establish the rate of BDD among patients 
seeking cosmetic procedures.  Ninety-one patients seeking facial cosmetic surgery and 50 
patients seeking non-cosmetic facial procedures were recruited from a university 
cosmetic surgery practice, a university otorhinolaryngology practice, and a private 
cosmetic surgery practice.  Prior to their initial visit, patients completed packets of 
questionnaires, including demographic questions and measures to assess body image 
dissatisfaction, BDD symptoms, and depression.  Surgeons and nurses rated the severity 
of patient appearance concerns using a rating scale.  Surgeons, nurses, and laypersons 
also rated a sample of patient photographs.  Percentages of patients who screened positive 
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for BDD on a self-report measure in combination with a surgeon rating of minimal or no 
deformity were calculated.  Eight percent of the cosmetic group and 7% of the non-
cosmetic group met criteria for BDD.  Patients with BDD symptoms reported greater 
depression and body image dissatisfaction as compared to patients without BDD 
symptoms. There was poor diagnostic correspondence between the two self-report 
measures of BDD.  Nurses and surgeons rated defects similarly.  Surgeons rated 
appearance concerns as more noticeable as compared to laypersons.  These results 
suggest that BDD is not uncommon among patients seeking facial cosmetic procedures. 
 
 
 
x
 
  
1. INTRODUCTION 
 
More than 50% of women and slightly less than 50% of men report dissatisfaction 
with their appearance (Garner, 1997).  These statistics are hardly surprising given the 
over-emphasis American culture places on physical appearance.  Dissatisfaction with 
one’s physical appearance is thought to motivate many behaviors—weight loss, exercise, 
cosmetic use, and cosmetic medical treatments including plastic surgery (Sarwer & 
Didie, 2002).   According to the American Society of Plastic Surgeons (ASPS), 6.6 
million people underwent cosmetic procedures in the United States in the year 2002.   
While some body dissatisfaction can be considered “normative”, for a minority of 
individuals, preoccupation with bodily flaws (though slight or even non-existent) can 
result in excessive psychological distress and significant functional impairment in daily 
activities.  These individuals are thought to suffer from the psychiatric disorder body 
dysmorphic disorder (BDD).  BDD is defined as an extreme preoccupation with an 
imagined or slight defect which causes significant distress and impairment in everyday 
functioning (APA, 2000).  
An incidence study of BDD in a cosmetic surgery population determined that   
approximately 7% of patients have BDD (Sarwer, Wadden, Pertschuk, & Whitaker, 
1998).  Prior to this study, the rate of BDD among cosmetic surgery patients had only 
been estimated at 2% (Andreasen & Bardach, 1977).   Recently, Phillips and colleagues 
published the first incidence study of BDD among patients seeking dermatologic 
procedures; 12% screened positive for BDD (Phillips, Dufresne, Wilkel, & Vittorio, 
2000).  However, methodological weaknesses of these studies necessitate the replication 
of these findings.   
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Examination of the incidence of BDD among patients seeking facial cosmetic 
procedures is warranted for several reasons.  First, BDD sufferers often report extreme 
dissatisfaction with facial features, such as the nose or skin (Phillips, McElroy, Keck, 
Pope, and Hudson, 1993; Phillips & Diaz, 1997).   Second, despite having a psychiatric 
illness, BDD sufferers frequently seek cosmetic procedures as a means of alleviating their 
distress (Phillips, et al., 1993; Veale, 2000; Phillips, Grant, Siniscalchi, & Albertini, 
2001).  
 According to the American Society of Aesthetic Plastic Surgery (ASAPS), a 
variety of medical specialists, including dermatologists and otorhinolaryngologists, 
perform cosmetic procedures each year (ASAPS, 2002).  However, the prevalence of 
BDD has only been investigated in cosmetic surgery and dermatology populations 
(Sarwer et al., 1998; Phillips et al., 2000).  Additionally, case reports from oral and 
maxillofacial practices suggest that BDD appears within these patient populations 
(Cunningham, Bryant, Manisali, Hunt, & Feinmann, 1996; Cunningham, Harrison, 
Feinmann, & Hopper, 1998).  Thus, it is likely that individuals with BDD would also 
present to otorhinolaryngology practices.  Studies investigating the rates of BDD in 
cosmetic settings have included patients seeking cosmetic surgery for any part of the 
body (Sarwer et al., 1998; Phillips, et al., 2000).   However, to date, the rate of BDD in 
cosmetic and medical settings has not been firmly established, nor has it been 
investigated among patients seeking only facial cosmetic procedures.  
In summary, BDD is a psychiatric disorder which causes significant distress and 
functional impairment for its sufferers.  While those with BDD are in need of psychiatric 
treatment, they are more likely to present to medical settings for treatment of their 
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perceived defect.  Studies of the clinical features of BDD have found that the majority of 
patients are concerned with a facial feature (Phillips, McElroy, Keck, Pope, et al., 1993; 
Phillips & Diaz, 1997).  Although recent studies have reported incidence rates of BDD 
among cosmetic surgery and dermatology clinics, future studies are needed to further 
establish the rate of BDD among patients seeking facial cosmetic procedures.   Thus, the 
present study was designed to investigate the rate of BDD among patients seeking facial 
plastic surgery in cosmetic surgery and otorhinolaryngology clinics.  Information about 
the rate of BDD among these populations may play an important role in the identification 
and assessment of these patients.     
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2. LITERATURE REVIEW 
 
2.1. History of the Diagnosis 
 
BDD was first described in the European medical literature by Morselli in 1886 
and referred to as “dysmorphophobia” (Morselli, 1886).  The condition was described as 
a subjective feeling of ugliness coupled with shame, despite a normal appearance.  
Similar symptoms have been categorized under a variety of names.  Janet (1903) reported 
cases of “l’obsession de la honte du corps” (obsession with shame of the body).  Later, 
Kraepelin (1909) described a “dysmorphophobic syndrome”, and urged that this 
syndrome be classified as a compulsive neurosis.   In the psychoanalytic literature, the 
case of the Wolf Man, who was so obsessed with his nose that he neglected all else, was 
described by Freud (1918) as “hypochondriacal paranoia.”  
Reports of BDD in the United States predated the International Classification of 
Disease (ICD) and DSM descriptions. In fact, reports of this disorder may have first 
surfaced in the cosmetic and dermatology literature.  In the 1960s, Edgerton and 
colleagues described “minimal deformity” and “insatiable” patients in the cosmetic 
surgery literature (Edgerton, Jacobson, & Meyer, 1960; Knorr, Edgerton, & Hoopes, 
1967).  These patients often requested multiple surgeries to correct slight or nonexistent 
defects, and reported high levels of dissatisfaction with their postoperative results, despite 
a technically successful procedure (Edgerton, et al., 1960).  Requests for multiple 
surgeries on slight or non-existent defects and dissatisfaction with surgical outcomes are 
features that are often observed among BDD patients who present for cosmetic 
procedures today.  
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Body dysmorphic disorder debuted in the U.S. psychiatric nosology in DSM-III 
where it is mentioned as an example of an atypical somatoform disorder (APA, 1980).  
BDD achieved diagnostic status and was officially termed ‘body dysmorphic disorder’ in 
DSM-III-R (APA, 1987).  The DSM-III-R differentiated the delusional and non-
delusional variants of BDD, with the former being classified as a delusional disorder, 
somatic type.  With the publication of DSM-IV (APA, 1994), the differentiation between 
the 2 subtypes is less clear.  This may reflect the growing body of research which 
suggests that the delusional and non-delusional subtypes are not distinct disorders but 
variations of the same disorder (BDD), which has a spectrum of symptomatology 
(Phillips, McElroy, Keck, Jr., Hudson, & Pope, Jr., 1994). (See Theoretical Issues below) 
Terms such as “beauty hyponchondria” and “dermatologic hypochondriasis” were 
used to describe BDD in the European literature prior to its entrance into psychiatric 
nosology (Sobanski & Schmidt, 2000).  These descriptive terms were initially classified 
as a form of monosymptomatic hypochondriacal psychosis (Thomas, 1984).  The 
condition was finally termed “body dysmorphic disorder” in the International 
Classification of Disease-10 (WHO, 1992).  ICD-10 criteria differentiate the non-
delusional and delusional variants of BDD, with the non-delusional subtype being 
classified as a hypochondriacal disorder, and the delusional variant as a persistent 
delusional disorder, not otherwise specified (WHO, 1992).    
DSM-IV-TR diagnostic criteria. In the DSM-IV-Text Revision (DSM-IV-TR), 
BDD is defined as (1) a preoccupation with an imagined defect in appearance or if a 
slight physical defect is present, the person’s concern is excessive (2) the preoccupation 
causes significant distress or impairment in social, occupational, or other important areas 
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of functioning and (3) the preoccupation is not better accounted for by another 
psychiatric disorder (APA, 2000).  Individuals with BDD who have preoccupations with 
imagined defects in appearance that are held with delusional intensity can also receive a 
diagnosis of Delusional Disorder, Somatic Type.  Currently, BDD is classified as a 
Somatoform Disorder.  However, this classification has been criticized as being neither 
“nosologocially nor aetiopathologically informed” (Phillips & Castle, 2002, pp. 101), and 
several researchers have argued that it should be considered an obsessive-compulsive 
spectrum disorder (Hollander, Cohen, & Simeon, 1993; Phillips, McElroy, Hudson, & 
Harrison, Jr., 1995).  (See Theoretical Considerations, below)   
  
2.2. Clinical and Demographic Features  
 
 To date, no large epidemiological studies of BDD have been conducted.  As a 
result, we must rely on smaller studies and case reports.  These studies have provided 
important information about the clinical features and demographic characteristics 
associated with BDD.   
Clinical Features 
 
Appearance preoccupations.  The hallmark characteristic of BDD is a 
preoccupation with appearance.  These preoccupations often focus on the face, head, 
skin, hair, nose, and facial asymmetry (Phillips, McElroy, Keck, Pope, et al., 1993; 
Phillips & Diaz, 1997).  Any area of the body can become the focus of preoccupation, 
and the complaint can be specific or vague (APA, 2000).  For example, a BDD patient 
may complain of “devious-looking eyebrows” (Phillips, 1991) or complain that a body 
part is simply ugly.  In one of the largest published studies of the clinical and 
demographic features associated with BDD to date (n = 188), Phillips and Diaz (1997) 
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reported that the most common areas of concern were the skin, hair, and nose.  People 
with BDD are usually concerned with more than one body part; the average BDD sufferer 
is concerned with three to four features (Phillips, McElroy, Keck, Jr., Pope, Jr., & 
Hudson, 1993; Phillips & Diaz, 1997).  Forty percent of BDD patients are concerned with 
one body part or one set of body parts (i.e., head), while approximately 37% are initially 
concerned with one body part and then develop preoccupations with more areas over time 
(Phillips, 1996).  Furthermore, in approximately 21% of those diagnosed with BDD, 
concerns with one body part disappear and shift to another feature over time (Phillips, 
1996).   
Intrusive thoughts. Most people with BDD describe being unable to stop thinking 
about their perceived defect, some to the extent that they are able to focus on little else.  
These obsessions are difficult to resist and control, and can become more intense in 
situations in which the person feels self-conscious or expects to be scrutinized (Hollander 
et al., 1993; Rosen, Reiter, & Orosan, 1995).  The meanings of these thoughts and 
preoccupations (i.e., the defective feature renders the person a failure, repulsive, and 
unattractive) have been characterized as overvalued ideas that can result in significant 
psychological distress (Rosen, et al., 1995).  
  Many BDD sufferers are unable to recognize that their concerns are excessive; 
others can acknowledge that their concern is exaggerated.  Level of insight can vary over 
the course of the disorder, ranging on a continuum from good insight to delusional 
thinking (Phillips & McElroy, 1993).  As noted above, while DSM-IV makes a 
classification distinction between BDD with delusions (delusional disorder, somatic type) 
and the non-delusional (somatoform disorder) variants of BDD, empirical investigation 
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has demonstrated that patients with non-delusional and delusional BDD do not differ in 
regard to demographics, clinical features, comorbidities, or treatment response (Phillips, 
McElroy, Keck, Jr., Hudson, & Pope, Jr., 1994).  Phillips and colleagues have suggested 
that BDD and its delusional variant may actually be one disorder in which thinking spans 
a continuum from obsessional thinking through overvalued ideation to delusional 
thinking (Phillips, et al., 1994).   
Compulsive behaviors.  People with BDD often engage in compulsive and time-
consuming behaviors, such as mirror checking, excessive grooming, skin picking, 
camouflaging, and excessive reassurance seeking about their appearance (Phillips, 1996).   
For example, 87% of BDD patients reported excessively checking their appearance in 
mirrors and other reflective surfaces (Phillips & Diaz, 1997).  Eighty-eight percent also 
reported camouflaging behaviors, such as using a hat to hide perceived facial or hair 
defects, using one’s hand to hide the defect, or wearing special clothing and makeup 
(Phillips & Diaz, 1997).  Individuals with BDD frequently avoid situations and clothing 
that might expose their defect.  For example, Phillips and colleagues reported that 97% of 
their BDD case report sample (n = 30) experienced avoidance of situations such as 
examining oneself in mirrors, swimming, gym class, shopping, dating, and sex  (Phillips, 
et al., 1993).    
These types of compulsive behaviors are often performed repeatedly in an attempt 
to calm anxieties surrounding appearance, or to avoid the feared ridicule and rejection of 
others (Phillips, 1996).  Many feel that they cannot resist engaging in some of these 
behaviors, even though the behaviors themselves may actually worsen their distress.  For 
example, skin picking or excessive mirror checking can actually increase worries about 
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the defect.  Skin picking can also worsen the defect itself (Phillips & Taub, 1995; 
Phillips, 1996).  These behaviors are often difficult to resist and as evidenced by case 
reports, can last for hours every day (Phillips, et al., 1993; Rosen, et al., 1995).   
Compulsive and avoidant behaviors are thought to contribute to the maintenance of BDD, 
as they prevent sufferers from habituating to the sight of their appearance and keep 
attention focused on the defective feature (Rosen, et al., 1995).   
Impairment of functioning.  The time spent in these compulsive behaviors often 
impairs social and occupational functioning (Phillips, et al., 1993).  Avoidance of social 
situations is common among sufferers of BDD so that they may avoid the feared scrutiny 
of their defect by other people (Phillips, 1996).  In severe cases, patients may become 
housebound, only leaving their homes at night to avoid the ridicule of others, dropping 
out of school, avoiding job interviews or not working at all to avoid public exposure 
(APA, 2000).  For example, 98% of persons with BDD reported interference with their 
social and occupational functioning, and approximately 30% reported becoming 
housebound as a result of their condition (Phillips & Diaz, 1997).    
High levels of perceived stress have bee reported among BDD sufferers 
(DeMarco, Li, Phillips, & McElroy, 1998).  The emotional distress experienced by 
people with BDD spans a spectrum, ranging from mild distress to severe and disabling 
emotional pain, sometimes to the extent that the individual considers or attempts suicide 
(Phillips, 1996).  Phillips (2000) conducted an investigation of the quality of life of 62 
BDD sufferers using the Medical Outcomes Study 36-item Short-Form Health Survey.  
Scores of individuals with BDD were compared to quality of life norms for the general 
U.S. population and for patients with depression or a medical illness.  BDD sufferers 
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scored lower in all areas of mental-health related quality of life (i.e., role limitations due 
to emotional problems, social functioning) as compared to the U.S. norms and patients 
with diabetes, depression, or myocardial infarction (Phillips, 2000).  Furthermore, BDD 
severity was negatively associated with quality of life even after depression was 
controlled.  BDD sufferers with delusions reported poorer quality of life than those with 
the non-delusional variant of the disorder (Phillips, 2000).     
Self-harm and suicidality.  For some sufferers with BDD, the emotional 
desperation to correct the perceived defect can lead to damage to their bodies (Phillips, 
1996).  Utilization of harsh chemicals is not uncommon in the pursuit of perfection.  For 
example, Phillips (1996) reports an incident in which a BDD sufferer super-glued his ears 
because they “stuck out” too much (p. 147).  Skin picking can involve the use of 
implements such as knives and razor blades, which can cause noticeable damage (Phillips 
& Taub, 1995).  In some cases, individuals with BDD have become so desperate that they 
have performed surgery on themselves.  Veale (1996) described nine BDD patients who 
reported that they performed “Do It Yourself” procedures in order to reduce their 
appearance-related distress.  For example, one male patient reported stapling his facial 
skin in order to make his “loose” skin appear more taut.  Another case report described a 
female BDD sufferer who picked at a pimple on her neck until her carotid artery was 
exposed, an incident that was life-threatening and required emergency surgery 
(O'Sullivan, Phillips, Keuthen, & Wilhlem, 1999). 
 The emotional pain and desperation experienced by BDD sufferers can lead to 
suicidal ideation and suicide attempts.  According to one study, 40% of BDD sufferers 
experienced suicidal ideation during the course of their illness (Phillips, McElroy, Keck, 
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Harrison, et al., 1993).  A recent study that compared Axis I comorbidity among 
treatment-seeking and non-treatment seeking BDD patients reported rates of lifetime 
suicidal ideation to be as high as 85% (Gunstad & Phillips, 2003).   
Attempted suicide rates gathered from studies investigating the clinical features of 
BDD appear to range from 17% to 33% (Phillips, et al., 1993; Phillips & Diaz, 1997; 
Veale, et al., 1996; Phillips & Taub, 1995).  In the dermatology literature, case reports of 
completed and attempted suicides have indicated that the majority of these individuals 
suffered from BDD (Cotterill, 1981; Cotterill & Cunliffe, 1997).  While the rates of 
suicide attempts vary among these studies, it is evident that suicidality is a significant 
problem associated with BDD.  
Demographic Features 
 
  Age of onset.   BDD typically begins in adolescence, however, it is usually 
diagnosed years later, partly because of the sufferers’ reluctance to discuss their concerns 
(APA, 2000).  Phillips & Diaz (1997) determined in their large sample that the mean age 
of patients who present for treatment is early to mid-thirties, while the mean age of onset 
was 16.  Another study investigating the demographic features associated with BDD 
reported that the average age of onset was 17.9 years (Veale, et al., 1996).    
            Course.  No prospective studies have elucidated the course of BDD.  Case reports 
suggest that BDD tends to be a chronic rather than episodic disorder, with symptoms 
waxing and waning over time (Phillips, 1996).  One study examining gender differences 
in BDD found that 83% of female BDD sufferers and 86% of male sufferers reported a 
continuous course of illness; 17% (female) and 14% (male) reported episodic courses 
(Phillips & Diaz, 1997).  Severity and delusionality can vary with time as well, 
sometimes for no apparent reason (Phillips, et al., 1993).   Phillips & Diaz (1997) 
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reported that approximately 60% of BDD patients report that their symptoms had 
worsened with time.  Remission from BDD symptoms without treatment appears to be 
infrequent.  A chart review study of BDD patients who entered into psychiatric treatment 
determined that only a few patients maintained a full remission (Phillips, Grant, & 
Albertini, 1999).   
Gender differences.   Several studies have examined gender differences among 
BDD patients.  BDD appears to be diagnosed with approximately equal frequency in 
women and men (APA, 2000).  In one of the largest studies of BDD patients published to 
date (n = 289), 48% were male and 52% were female (Phillips, Grant, Siniscalchi, & 
Albertini, 2001).  Nevertheless, there is some debate regarding the sex ratio for body 
dysmorphic disorder.  Some studies have reported greater incidence of female sufferers.  
For example, one study of British patients with BDD found that 76% of their sample (n = 
50) was female (Veale, et al., 1996).  Still, other studies have reported a preponderance of 
male patients.  For instance, a retrospective chart review study of 50 patients with BDD 
revealed that 62% of the sample was male (Hollander, et al., 1993).    
Culture and its influence on sex roles may be another factor impacting the gender 
ratio among BDD patients.  A study which examined demographic and clinical 
characteristics of Japanese BDD sufferers who sought cosmetic surgery reported that 
70% of their sample was male (Fukuda, 1977).  Another study of demographic features of 
Japanese patients seeking cosmetic surgery found a similar difference, with 20% (n = 85) 
of male patients receiving a diagnosis of BDD, compared to only 2.7% of women in the 
sample (n = 113) (Ishigooka, Iwao, Suzuki, Fukuyama, Muraski, & Miura, 1998).  The 
authors of this study suggest that the gender difference may reflect the sex roles in 
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Japanese culture regarding the initiating of interpersonal relationships after adolescence 
(Ishigooka, et al., 1998).   
Two studies have specifically investigated gender-related differences among BDD 
sufferers (Phillips & Diaz, 1997; Perugi, Akiskal, Giannotti, Frare, Di Vaio, & Cassano, 
1997).  One found that while both men and women were similar in terms of most 
demographic and clinical characteristics (i.e., age of onset, course of illness, symptom 
severity and impairment in functioning), men were more likely to be single than their 
female counterparts (Phillips & Diaz, 1997).  Additionally, gender appears to impact the 
area of preoccupation, with women being more likely than men to be concerned with 
their hips and weight; women were also more likely to use make-up for camouflage and 
to pick their skin.  In contrast, men were more likely to be preoccupied with their 
genitals, body build (i.e., being too skinny or not muscular), and hair thinning (Phillips & 
Diaz, 1997).   
The second published study of gender differences among BDD sufferers (n = 58) 
also reported differences in areas of preoccupation (Perugi, et al., 1997).  Women in this 
sample were more likely to be preoccupied with breasts and legs, while men again were 
more likely concerned with their genitals, height, and excessive body hair.   
Muscle dysmorphia.  While the gender ratio among BDD sufferers appears to 
equal, a newly investigated form of BDD, muscle dysmorphia is thought to affect more 
men than women.  The term ‘muscle dysmorphia’ refers to a preoccupation with being 
insufficiently large and muscular (Pope, Gruber, Choi, Olivardia, & Phillips, 1997).  The 
difference in gender ratio is thought to be a result of the differing beauty and appearance 
ideals for men and women.  Similar to “general” BDD, patients with muscle dysmorphia 
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tend to engage in compulsive behaviors (e.g., compulsive work-outs, weight lifting and 
dieting/use of food supplements), reassurance seeking, and camouflaging behaviors (e.g., 
wearing extra layers of clothing to appear bulkier).  Additionally, patients with this 
disorder may abuse anabolic steroids in order to ‘correct’ their defect, a supposed lack of 
muscle.  Individuals with muscle dysmorphia also experience significant social and 
occupational impairment, often because their weight lifting and eating regimens consume 
so much time.  While not included in the DSM-IV, further research is needed to 
investigate the epidemiology and etiology of this disorder (Pope, et al., 1997).   
2.3. Prevalence 
 
 BDD is not considered to be a rare disorder.  It is estimated that it affects 1-2% of 
the general population and 4-5% of people seeking medical treatment in outpatient 
settings (Phillips, 1996).  These prevalence rates may be underestimates given the 
extreme embarrassment and reluctance of people with BDD to seek psychological 
assistance for their symptoms.  Furthermore, because BDD is often accompanied by 
depression, anxiety, and other symptoms that are easier to discuss, the rates of 
misdiagnosis for this disorder are potentially quite high (Phillips, 1996).  People with 
BDD often have their distress trivialized by others, or they are thought to be excessively 
vain, thus further inhibiting them from seeking treatment (Phillips, 1996).  Veale and 
colleagues (1996) reported that 38% of their sample (n = 50) would not disclose their 
concerns to their general practitioners for fear of embarrassment, not being understood, or 
not being taken seriously.  Of the remaining 62% who did mention their concerns to their 
general practitioner, 83% were dissatisfied with their response.  These statistics 
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underscore the need for education about BDD among medical professionals in order to 
facilitate diagnosis and treatment.   
To date, no large-scale epidemiological surveys investigating the prevalence of 
BDD in the general population have been completed.  However, studies have examined 
the prevalence of BDD in a variety of settings, including university, community, medical, 
cosmetic surgery, and psychiatric populations.   
University populations.  An early study of the prevalence of BDD was conducted 
among a sample of American undergraduate students (n = 258; 57% female) (Fitts, 
Gibson, Redding, & Deiter, 1989).  Using three questions derived from DSM-III-R 
diagnostic criteria for BDD, investigators asked the students to rate the extent to which 
they agreed with each question on a Likert scale (1 = strongly disagree to 6 = strongly 
agree).   
Seventy percent of the sample reported some dissatisfaction with their bodies.  
Forty-six percent reported experiencing preoccupation with some aspect of their 
appearance, and 48% noted that they tend to exaggerate the extent of the defect (Fitts, et 
al., 1989).  Twenty eight percent of the sample endorsed agreement with all three 
questions, suggesting the presence of some BDD symptoms.  However, this number is 
likely inflated, given that the questions used to assess for BDD symptoms did not assess 
for functional impairment and weight-related concerns were excluded from analysis. 
Furthermore, this study did not incorporate a measure of defect severity.  Sex differences 
were also noted among this sample, with significantly more women reporting agreement 
with each of the questions (Fitts, et al., 1989).   
 
 
 
16
Results of this study suggested that the diagnostic criteria for BDD are vague and 
may incorrectly diagnose large portions of the population, given the discontent many 
people (especially women) report about their bodies.  Furthermore, it calls into question 
the validity of using measures based solely on diagnostic criteria. 
Another study investigated the rate of BDD among college undergraduate 
students but used DSM-IV diagnostic criteria (Biby, 1998).  In this study, 102 students 
(78 females, 24 males) completed a self-report questionnaire, which incorporated 
questions related to the DSM-IV diagnostic criteria for BDD and eating disorders on a 
Likert scale (1 = strongly disagree to 5 = strongly agree).  Individuals who reported 
eating disordered symptoms were excluded from the analyses.  Results of this study 
indicated that 13% of the sample met criteria for BDD.  The small sample size, reliance 
on a self-report measure (without reported psychometric properties), and lack of a rating 
of the severity of the participants’ appearance concerns limit the significance of these 
results.  
More recently, Sarwer and colleagues (2004) examined the rate of BDD among a 
sample of 559 college women using the Body Dysmorphic Disorder Questionnaire 
(BDDQ; Phillips, 1996), a measure that is based upon DSM-IV diagnostic criteria for 
BDD.  When women who reported primary concerns with weight and shape were 
excluded from analyses, 2.5% (n = 14) met criteria for BDD (Sarwer, Cash, Magee, 
Williams, et al., 2004).   
Another recent study investigated the prevalence rate of BDD in a sample of 
German college undergraduates (Bohne, Wilhelm, Keuthen, Florin, Baer, & Jenike, 
2002).  One hundred thirty-three students completed self-report questionnaires that 
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assessed BDD symptoms, as well as obsessive-compulsive and depressive symptoms and 
skin picking.  Approximately 5% of this sample (n = 8) met DSM-IV criteria for BDD as 
assessed by the Body Dysmorphic Disorder Questionnaire (BDDQ; Phillips, 1996).   
Bohne and colleagues also conducted a cross-cultural comparison study 
investigating the rates of BDD among American and German college students (Bohne, 
Keuthen, Wilhelm, Deckersbach, & Jenike, 2002).  One hundred one American college 
undergraduates completed self-report questionnaires, including the Body Dysmorphic 
Disorder Questionnaire (BDDQ; Phillips, 1996).  The American college students’ 
responses were then compared to those of German college students, who had been 
reported to have a 5.3% rate of BDD (Bohne, Wilhelm, Keuthen, et al., 2002).  Seventy-
four percent of American students reported being very concerned about parts of their 
body, a rate similar to that reported by Fitts (1989).  However, when individuals reporting 
weight-related preoccupations were eliminated from analyses, 4% (n = 4) of the 
American sample met DSM-IV criteria for BDD (Bohne, Keuthen, Wilhelm, et al., 
2002).  The difference in rates of BDD among German and American students in this 
study was non-significant.   
The reliance upon self-report measures and small sample sizes in these university 
investigations limits the significance of their findings.  Furthermore, these studies did not 
sufficiently assess for the first diagnostic criterion for BDD, which states that the 
individual’s excessive concern is related to an imagined or minimal defect in appearance.  
However, these studies confirm the hypothesis that BDD is not a rare disorder, as the 
rates obtained in these studies are similar to the expected population rates. 
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A recent study of the rates of BDD among a Turkish college student population 
has attempted to address the limitations of other university prevalence studies (Cansever, 
Uzcun, Donmez, & Aytekin, 2003).  Four hundred and twenty female college students 
were asked to complete a self-report questionnaire that included questions based upon 
DSM-IV criteria for BDD as well as several items from the Body Dysmorphic Disorder 
Examination (BDDE; Rosen & Reiter, 1996).  If participants answered “yes” to the BDD 
diagnostic questions, they were asked to complete a face-to-face clinical interview with a 
psychiatrist, who then administered the Structured Clinical Interview for DSM-IV 
(SCID).  Specific questions were also asked by the psychiatrist to determine the level of 
insight the participants had regarding their appearance concerns. Participants with visible 
appearance defects, including high body mass indices, were excluded from the final 
analyses.   
Results of this study indicate that 4.8% (n = 20) of the students met criteria for 
BDD.  Similar to other reports, the most common areas of concern were related to the 
head or face.  None of the students who met criteria for BDD were deemed to have 
delusional levels of preoccupation, although 40% were classified as having over-valued 
ideas about their appearance (Cansever, et al., 2003).  
The larger sample size, use of clinical interviews, and exclusion of participants 
with weight-related concerns add strength to the validity of the findings from this study.  
It is also noteworthy that the rate obtained (4.8%) is similar to those found among 
American (4%) and German (5.3%) college student samples (Bohne, et al., 2002).  
However, most of these university prevalence studies have used predominantly female 
samples.  For example, in Bohne and colleagues’ (2002) cross-cultural comparison study, 
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82.2% of the American and 73.7% of the German college undergraduates were female, 
whereas other studies have relied upon exclusively female samples (Cansever, et al., 
2003; Sarwer, Cash, et al., 2004).  Thus, the rates of BDD reported in these studies may 
underestimate the prevalence of BDD in university samples, since BDD is thought to be 
equally prevalent among men and women (APA, 2000).  
Community samples.  Bienvenu and colleagues (2000) investigated the rate of 
BDD in a randomly selected community sample of 73 individuals and 300 of their first-
degree relatives as part of a larger study investigating the family history of patients with 
OCD.  Using structured clinical interviews, 3% of control participants and 1% of first-
degree relatives were diagnosed with BDD (Bienvenu, et al., 2000).    
One study to date has examined the prevalence of BDD in a sample of community 
women in the United States.  Otto and colleagues (2001) investigated the rate of BDD 
among a large (n = 976), population-based sample of depressed and non-depressed 
women who were participating in the Harvard Study of Moods and Cycles.  Structured 
clinical interviews were used to assess for the presence of BDD in this sample.  A .7% 
prevalence rate for BDD was found among this population (Otto, Wilhelm, Cohen, & 
Harlow, 2001).   However, the authors note that this prevalence rate is likely an 
underestimate of the true prevalence of BDD in the population at large, notably because 
younger women (e.g., under 36 years of age) were not included in the sample.  Given that 
adolescence is typically the age of onset for BDD symptoms, samples including younger 
women would likely have higher prevalence rates of this disorder.  The higher rates of 
BDD obtained in university student samples (which were comprised of mostly women) 
support this contention (Bohne, et al., 2002).  
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 Rates of BDD have also been investigated in an Italian epidemiological study of 
somatoform disorders (Favarelli, Salvatori, Galassi, Aiazzi, et al., 1997).  This study used 
an interview based upon DSM-III-R criteria to diagnose BDD as well as other 
somatoform disorders.  Results indicate that .7% (n = 5) of the 673 participants met 
criteria for BDD.  All five participants who met criteria for BDD were women.   
Of note, the rate reported in the Italian sample is identical to the rate reported by 
Otto and colleagues (2001).  However, the use of DSM-III-R criteria, which does not 
include impairment in functioning, limits the generalizability of the Italian sample 
finding.  Additionally, more women than men were included in the Italian study (55% 
versus 45%), and there was a tendency in this sample for younger people to decline 
participation (Faravelli, et al., 1997).  Thus, the rates of BDD reported among community 
samples to date are likely underestimates of the true rate of BDD in the population.   
General medical populations. To date, only preliminary data on the prevalence of 
BDD in a general medical outpatient setting has been collected.  Phillips and colleagues 
have reported that of 316 patients screened in an outpatient clinic, 4.4% were found to 
have BDD (Phillips, 1996).  Given that most patients are required to obtain referrals from 
their primary care physicians to see other specialists, BDD may be relatively common in 
this setting.  More research about the rates of BDD among patients seeking general 
medical treatment is necessary.  
Cosmetic surgery and dermatology clinics.  Investigations of the prevalence of 
BDD in specialty medical settings have found higher rates of BDD in these populations 
as compared to the general population rate.   Based on a clinical interview, 15% of 
Japanese cosmetic surgery patients  (n = 415) were diagnosed with BDD (Ishigooka, et 
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al., 1998).  Diagnosis was made using ICD-10 criteria for BDD.  The majority of patients 
(90.6%) sought facial cosmetic procedures, with the nose, eyelids, and chin being the top 
three features for which surgery was desired (Ishigooka, et al., 1998).  In contrast, an 
investigation of American cosmetic surgery patients that used a questionnaire specifically 
designed to assess the presence of BDD (Body Dysmorphic Disorder Examination, Self-
Report form; Rosen & Reiter, 1996) found that 7% met diagnostic criteria (Sarwer, et al., 
1998).  Patients in this sample sought a variety of procedures, with rhytidectomy 
(facelift) and blepharoplasty (correction of sagging eyelids) being the most common 
(Sarwer, et al., 1998).  Of the 7 patients who screened positive for BDD, 5 sought 
correction of a facial feature, consistent with clinical reports that the face is the most 
common focus of the preoccupation.  
An investigation of the prevalence of BDD in dermatology clinics that also used a 
questionnaire (Body Dysmorphic Disorder Questionnaire-Dermatology Version (BDDQ-
DV); Dufresne, Phillips, Vittorio, & Wilkel, 2001) to assess the disorder determined that 
approximately 12% (n = 268) of patients met diagnostic criteria (Phillips, et al., 2000).   
When patients with obvious appearance defects were excluded from the sample, the rate 
of BDD increased to 15% (n = 211) (Phillips, et al., 2000).  Patients were sampled from a 
community dermatology clinic and a university-based outpatient dermatology clinic.   
The rates of BDD differed among these samples (14.4% for the community dermatology 
practice and 10% for the university-based practice).  However, when patients with 
obvious appearance defects were excluded, the rates between the two settings were nearly 
equal (15.6% for the community setting, and 14.7% for the university setting) (Phillips, et 
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al., 2000).  Of the 12% who met criteria for BDD, the majority reported concerns with 
acne or benign vascular lesions (Phillips, et al., 2000).   
A smaller study investigating the rate of BDD in 46 patients seeking 
dermatological cosmetic surgery found that 15% met criteria for BDD (Dufresne, et al., 
2001).  This study utilized 2 measures of BDD symptomatology: 1) The Body 
Dysmorphic Disorder Diagnostic Module (BDDDM), a brief, semi-structured interview, 
and 2) the BDDQ-Dermatology version, a modified version of the original BDDQ 
(Phillips, 1996) which substituted Likert scales for questions inquiring about symptom 
severity instead of the ‘yes/no’ responses found in the original version (Dufresne, et al., 
2001).  The BDDQ-Dermatology version was found to over-diagnose BDD by 4% when 
compared to the BDDDM (Dufresne, et al., 2001).  Still, these results indicate that BDD 
is relatively common in dermatology settings.  
A recent study of 156 patients seeking treatment for mild acne at a university-
based dermatology clinic in Turkey found that 8.8% (n = 14) of this sample met DSM-IV 
criteria for BDD (Uzun, Basoglu, Akar, Cansever, Ozsahin, et al., 2003).  This study 
utilized a self-report questionnaire as well as the Structured Clinical Interview (SCID) for 
DSM-IV that included diagnostic criteria for BDD.  Participants who met criteria for 
BDD were re-examined by a second psychiatrist who was blind to the results of the first 
assessment.  Of the patients who met criteria for BDD, all had preoccupations with areas 
in addition to their skin, with hair, nose, and facial concerns predominating.  While the 
rate of BDD in this sample was lower than that reported by Phillips and colleagues 
(2000), this sample was restricted to patients with acne.  Overall, the 8.8% rate found in 
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this investigation suggests that BDD is more common in dermatology settings than in the 
general population.     
The incidence of BDD has also been investigated among individuals with visible 
deformities undergoing reconstructive surgical procedures (Sarwer, Whitaker, Pertschuk, 
& Wadden, 1998).  Sixteen percent reported distress and preoccupation consistent with 
BDD, although the nature of the defect precludes the formal application of the diagnosis.  
BDD cases also have been reported in orthodontics and maxillofacial surgery clinics 
although the prevalence rates in these clinics have not been investigated (Cunningham, et 
al., 1996; 1998).   
Given that surgeons from a variety of fields perform cosmetic procedures, it is 
likely that BDD patients also present to other specialty clinics.  The need for further 
assessment in other specialty clinics is underscored by the results of a study investigating 
the rate of non-psychiatric treatment sought by patients with BDD (Phillips, et al., 2001).  
BDD patients in this sample reported receiving treatment from orthodontists and 
paraprofessionals who perform treatments such as electrolysis in addition to cosmetic 
surgery and dermatological treatments.   
In summary, the rate of BDD appears to be higher in cosmetic settings as 
compared to the general population.  Previous studies have reported rates of BDD 
ranging from 7%-15% in cosmetic and dermatological settings (Sarwer, et al., 1998; 
Phillips, et al., 2000; Dufresne, Jr., et al., 2001; Uzun, et al., 2003).  However, the use of 
different assessment tools, lack of appropriate control groups, and the lack of defect 
severity ratings in most of these studies limit the generalizability of their findings.   
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Psychiatric Populations 
Other investigations have sought to identify the rates of BDD among individuals 
with other psychiatric disorders.  These studies suggest that this disorder may be more 
common than previously thought.   
Heterogeneous psychiatric populations.  The importance of specifically inquiring 
about BDD symptoms is further demonstrated by an investigation that compared the 
prevalence of BDD in 2 groups of 500 heterogeneous psychiatric patients presenting for 
treatment (Zimmerman & Mattia, 1998).  One group was assessed for the presence of 
BDD using the Structured Clinical Interview for DSM-IV, and the other group was 
evaluated with a routine, unstructured clinical interview.  No patients in the group that 
was assessed via clinical interview received a diagnosis of BDD.  However, sixteen 
patients (3.2%) of the SCID-assessed sample were found to have BDD.  Among those 
receiving a diagnosis of BDD, depressive and anxiety disorder were the most common 
comorbid conditions (Zimmerman & Mattia, 1998).  
  Brawman-Mintzer and colleagues (1995) investigated the rate of BDD among 
patients with a primary diagnosis of social phobia (n = 54), obsessive-compulsive 
disorder (n = 53), generalized anxiety disorder (n = 32), panic disorder (n = 47), major 
depressive disorder (n = 42), and among a sample of normal comparison subjects (n = 
33).  Patients were assessed for the presence of BDD with a “SCID-Patient version-like 
module” developed by Phillips and colleagues (1995) (Brawman-Mintzer, et al., 1995).    
Results of this study revealed an overall rate of 5% (n = 11) of BDD among patients.  
Specifically, 11% of patients with a primary diagnosis of social phobia, 8% with OCD, 
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and 2% of patients with panic disorder received a diagnosis of BDD.  None of the 
depressive, generalized anxiety, or normal comparison subjects met criteria for BDD.   
 The rate of BDD has also been investigated among adult and adolescent 
psychiatric inpatients (Grant, Kim, & Crow, 2001).  One hundred twenty two 
consecutively admitted patients at a university hospital completed the BDDQ.  If patients 
screened positive for BDD on this measure, they were evaluated using a semi-structured 
clinical interview based upon DSM-IV BDD diagnostic criteria.  Thirteen percent (n = 
16) of this sample met diagnostic criteria for BDD.  Ninety-two percent of those 
diagnosed with BDD also carried an affective disorder diagnosis, and 69% of those with 
BDD had a comorbid substance abuse diagnosis (Grant, et al., 2001).  Of note, none of 
these patients had been diagnosed with BDD by their treating hospital physician.  All 
sixteen patients indicated to the research team that they would not voluntarily discuss 
their appearance concerns unless directly queried.  This study further underscores the 
need for assessment of BDD in psychiatric settings as well as the tendency of patients 
with BDD to be reluctant to discuss their concerns.          
Specific psychiatric populations.  Assessment of BDD among patients with 
depression is of importance given the high rates of comorbidity for these two disorders 
(Gunstad & Phillips, 2003).  In a study that utilized a semi-structured interview to assess 
for BDD among atypical depression patients (Phillips, Nierenberg, Brendel, & Fava, 
1996), 13.8%  (n = 80) met criteria for BDD.  Of note, in this sample, no patients 
mentioned their appearance concerns during the extensive assessment they underwent 
prior to being administered the diagnostic module for BDD.  This study underscores the 
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need for professionals to ask about symptoms of BDD even if the patient initially 
presents for another disorder.   
Another study also investigated the prevalence of comorbidities among patients 
with atypical depression using a clinical interview and the SCID for DSM-III-R (Perugi, 
Akiskal, Lattanzi, Cecconi, Mastrocinque, Patronelli, Vignoli, & Berni, 1998).  In this 
sample, 42% of patients (n = 86) reported a lifetime history of BDD, suggesting that 
BDD may commonly occur with atypical depression. 
More recently, the prevalence of BDD was investigated in a sample of 350 
consecutive outpatients with major and atypical depression (Nierenberg, Phillips, 
Petersen, Kelly, Alpert, et al., 2002).  Patients were evaluated with the Structured Clinical 
Interview for DSM-III-R SCID, the SCID for personality disorders (SCID-II), and a 
module designed to assess for BDD symptoms (BDDM; Phillips, 1996).  This study 
found an 8% lifetime prevalence of BDD, whereas 6.6% of the total sample currently met 
diagnostic criteria (Nierenberg, et al., 2002).   Patients with BDD had an earlier age of 
onset for depression, as well as longer duration of current episodes.  Interestingly, this 
study also found that a higher percentage of patients with atypical depression had a 
lifetime diagnosis of BDD (14%) as compared to patients with major depression (5%).   
Similarly, a significantly higher rate of current BDD was found among patients with 
atypical depression (12%) as compared to patients with major depression (4%).  These 
findings are consistent with previous studies that have found high rates of atypical 
depression among patients with BDD (Perugi, et al., 1998; Phillips, Nierenberg, Brendel, 
& Fava, 1996).     
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 The prevalence of BDD has also been investigated among outpatients with a 
primary diagnosis of an anxiety disorder (Wilhelm, Otto, Zucker, & Pollack, 1997).  
BDD was assessed using the SCID-II with specific questions regarding BDD (Wilhelm, 
et al., 1997).  Approximately 7% of patients met diagnostic criteria for BDD (11 out of 
165).  Specifically, 12% of the social phobia patients, 7.5% of OCD patients, and 3.8% of 
panic disorder patients met criteria for BDD.   
In the DSM-IV field trial for obsessive-compulsive disorder (OCD), the 
prevalence of BDD was assessed in a sample of 442 patients with a primary diagnosis of 
OCD using the Columbia Body Dysmorphic Disorder Diagnostic Questionnaire and the 
Yale-Brown Obsessive Compulsive Scale (version modified for BDD) (Simeon, 
Hollander, Stein, Cohen, & Aronowitz, 1995).  Twelve percent of patients with OCD also 
met lifetime criteria for BDD (Simeon, et al., 1995).  Other studies of OCD patients have 
reported higher rates of BDD among OCD patients, ranging from 14.5% to 37% 
(Bienvenu, Samuels, Riddle, Hoehn-Saric, et al., 2000; Phillips, Gunderson, Mallya, 
McElroy, & Carter, 1998; Piggot, L'Heureux, Dubbert, Bernstein, & Murphy, 1994; 
Hollander, et al., 1993).  
A study investigating psychological correlates of trichotillomania patients 
reported high rates of body image dissatisfaction unrelated to hair pulling among their 
sample.  Twenty-two percent (n = 62) were rated as having probable BDD (Soriano, 
O'Sullivan, Baer, Phillips, McNally, & Jenike, 1996), although it should be noted that 
BDD was assessed via a screening form and not a diagnostic measure.  
The rate of BDD among inpatients with anorexia nervosa has also been 
investigated using the Body Dysmorphic Disorder Questionnaire and a semi-structured 
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diagnostic interview based upon DSM-IV BDD criteria (Grant, Kim, & Eckert, 2002).  
Thirty-nine percent (n = 16) of this sample met diagnostic criteria for BDD due to 
appearance concerns that were unrelated to weight or shape.  In this sample, a comorbid 
diagnosis of BDD was associated with lower overall functioning, as assessed by the 
Global Assessment of Functioning (GAF) scale (APA, 1994).  Comorbid BDD was 
associated with earlier onset of anorexia, higher levels of delusionality related to 
appearance concerns, and a history of more hospitalizations and suicide attempts as 
compared to anorexic patients without BDD.  Despite the small sample size, this study 
suggests that BDD may be more common among patients with eating disorders than 
previously thought.   
 In summary, studies investigating the prevalence of BDD among specific and 
heterogeneous psychiatric populations indicate that BDD frequently co-occurs with mood 
and anxiety disorders.  There is growing evidence that BDD also co-occurs with eating 
disorders, particularly anorexia nervosa.  These findings suggest the need for assessment 
of BDD symptoms among patients seeking treatment for other psychiatric disorders.  
2.4. Comorbidity 
Other studies have investigated comorbidities associated with BDD by assessing 
the frequencies of other psychiatric disorders among patients with a primary diagnosis of 
BDD.   According to a study which investigated comorbidities among 293 patients with 
BDD, the mean number of lifetime comorbid Axis I diagnoses was two (Gunstad & 
Phillips, 2003).  Depression, obsessive-compulsive disorder, social phobia, and substance 
abuse disorders are the most common co-occurring disorders with BDD.  Personality 
disorders are also common among patients with BDD.   
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Depression.  Depression has the highest rate of co-occurrence with BDD, with a 
lifetime rate of 82% and a current rate of 60% (Phillips & Diaz, 1997).  A more recent 
study comparing comorbidity rates between a sample of BDD patients from a 
phenomenology study (n = 175) and a sample of BDD patients participating in 
pharmacotherapy treatment studies (n = 118) found a lifetime rate of major depression of 
84 - 90% and a current rate of 54-69% (Gunstad & Phillips, 2003).  Onset of depression 
in patients with BDD tends to be either concurrent with or occurring after the onset of 
BDD (Phillips, et al., 1993; Gunstad & Phillips, 2003).  Onset of depression preceded the 
onset of BDD symptoms in 22% of cases (Gunstad & Phillips, 2003).  The high rate of 
comorbidity between these two disorders has led to speculation that these disorders share 
a common etiology and may both be considered affective spectrum disorders (Phillips, et 
al., 1995).  (See Theoretical Issues) 
Obsessive compulsive disorder (OCD).  While there are similarities among the 
clinical features of OCD and BDD, rates of OCD among patients with a diagnosis of 
BDD are lower as compared to rates of depression.  Current comorbid rates of OCD 
range from 6% (Veale, et al., 1996) to 30% (Gunstad & Phillips, 2003; Phillips & Diaz, 
1997; Phillips, et al., 1993); lifetime rates of OCD range from 30% (Gunstad & Phillips, 
2003; Phillips, et al., 1993) to 78% (Sobianski & Schmidt, 2000).   As with depression, 
there is speculation that these disorders share a common etiology, with the degree of 
comorbidity supporting this hypothesis (See Theoretical Issues).   
Social phobia.   Social phobia also appears to be another common condition that 
co-occurs with BDD, with a lifetime rate of 38% (Phillips & Diaz, 1997).  A larger study 
of BDD and its comorbidities has confirmed this finding, with reported current rates of 
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social phobia of approximately 32% and lifetime rates of 37% (Gunstad &Phillips, 2003).  
Social phobia appears to predate the onset of BDD in almost all cases, according to 
several studies (Phillips, et al., 1993; Wilhelm, et al., 1997; Gunstad & Phillips, 2003).  
Wilhelm and colleagues have suggested that this pattern of comorbidity may have 
implications for uncovering the etiology of BDD (See Etiology).   
Substance abuse.  Co-occurring substance abuse and dependence disorders are 
also relatively common among patients with BDD.  Current rates ranging from 2% 
(Veale, et al., 1996) to 35% (Phillips & Diaz, 1997) have been reported in the literature, 
with lifetime rates reported to be 47% (Phillips, et al., 1993).  In a large study of BDD 
and Axis I comorbidity, the current rate of substance use disorders was reported to be 
13%, with a lifetime rates between 25-30% (Gunstad & Phillips, 2003).  Case reports 
indicate that BDD sufferers often use drugs or alcohol as an attempt to cope with their 
BDD symptoms (Phillips, 1996).  Recent age of onset data suggests that substance use 
disorders tend to develop after the onset of BDD symptoms (Gunstad & Phillips, 2003).   
  Axis II disorders.  Personality disorders have also been found to co-occur with 
BDD.  Among 50 cases of BDD, 72% were diagnosed with a personality disorder, with 
avoidant (38%), paranoid (38%), and obsessive-compulsive personality (28%) disorders 
being the most common (Veale, et al., 1996).  In a sample of 17 BDD patients, all 
patients had at least one personality disorder, with 13 (76.5%) having four or more Axis 
II diagnoses (Neziroglu, McKay, Todaro, & Yaryura-Tobias, 1996).  The majority of 
patients (94%) had cluster C personality disorders (Avoidant, Dependent, Obsessive-
Compulsive) (Neziroglu et al., 1996).  Another study revealed that 57% (n = 148) had at 
least one diagnosable personality disorder, with cluster C disorders again being the most 
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frequently diagnosed (Phillips & McElroy, 2000).  Thus, it appears that cluster C 
personality disorders, and particularly avoidant personality disorder are frequently 
comorbid with BDD.   
Gender differences in comorbidities.  The two studies that investigated gender 
differences among BDD sufferers have suggested that there are differences among men 
and women with respect to comorbid conditions (Phillips & Diaz, 1997; Perugi, et al., 
1997).  Two studies have suggested that women are more likely than men to have a 
history of eating disorders and anxiety disorders (Perugi, et al., 1997; Phillips & Diaz, 
1997).  Men are more likely to have a history of substance abuse or dependence (Phillips 
& Diaz, 1997) or bipolar disorder (Perugi et al., 1997).    
In summary, comorbidity rates among BDD patients appear to be quite high.  
Comorbidity rates also reflect the complexity of BDD, particularly with respect to 
diagnosis and treatment.  Recent data on comorbidity rates among patients with BDD 
suggest that comorbidity is associated with increased impairment in functioning and 
higher rates of suicidal ideation and attempts (Gunstad & Phillips, 2003).  Further study 
of comorbidity among individuals with BDD is needed to improve treatment of this 
disorder and to determine possible etiological relationships.    
2.5. Etiology 
 
To date, the etiology of BDD has received little attention in the literature.  
However, it has been purported that there are multiple factors involved in the etiology of 
BDD, including psychological, sociocultural, and neurobiological factors (Phillips & 
Castle, 2002).   
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Psychological Theories  
Psychoanalytic perspectives.  As discussed in Phillips (1991), psychoanalytic 
theories suggest that BDD arises from an unconscious displacement of sexual or 
emotional conflict or feelings of inferiority, guilt, or poor self-image onto a body part.  
Other psychoanalytic theories suggest that the perceived defect may symbolize another 
body part which is dysfunctional (i.e., preoccupation with the nose may indicate an 
impotent penis) (Phillips, 1991).  From this perspective, BDD symptoms may also be 
seen as an attempt to explain failures in life, particularly interpersonal problems, as it is 
seemingly less threatening to blame one’s appearance than oneself (Phillips, 1996).   
While these hypotheses are intriguing, they have not been empirically validated.  
Cognitive-behavioral theories. Explanations from a cognitive-behavioral 
perspective suggest that BDD arises from an interaction of cognitive, emotional, 
behavioral, and sociocultural factors.  Cognitive-behavioral models of the development of 
BDD have suggested that preoccupations with appearance are likely to develop during 
adolescence, since concerns about appearance are typically heightened during this 
developmental phase (Rosen, Reiter, & Orosan, 1995; Veale, Gournay, Dryden, 
Boocock, et al., 1996).  Often, changes in physical appearance are noticeable to others 
during adolescence, and this increased attention, particularly if it is negative, can 
predispose a person for developing dysfunctional beliefs about his appearance (Rosen, et 
al., 1995).   
Cognitive factors that appear to be instrumental in the development of BDD 
include unrealistic attitudes about body image that insist upon perfection and symmetry 
(Veale, et al., 1996).  For example, distorted beliefs, such as “If I am not perfect, no one 
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will accept me” may develop.  Such negative thoughts are then rehearsed, to the point 
that they become automatic and held with conviction.  Emotional distress, including 
feelings of disgust and shame, are thought to result from these distorted thinking patterns 
(Veale, et al., 1996; Rosen, et al., 1995).  Other cognitive factors, such as selective 
attention to the perceived defect and increased self-monitoring for the presence of 
appearance flaws, are thought to be maintaining factors in BDD (Veale, et al., 1996).  
 As discussed above, BDD patients tend to engage in repetitive and time-
consuming rituals, which typically serve to either check or avoid the perceived flaw 
(Veale, et al., 1996).  These compensatory behaviors appear to be attempts to reduce the 
distress resulting from the increased attention on the flaw.  However, they are thought to 
prevent the person from habituating to his appearance, and thereby maintain the cycle of 
increased attention, compulsive behaviors, and increased distress about one’s appearance 
(Rosen, et al., 1995).     
Socio-cultural perspectives.  Socio-cultural theories derive explanations for the 
etiology of BDD from the social histories of patients.  For example, being raised in a 
family that is rejecting, neglectful, and critical may be a social factor related to the 
development of BDD (Phillips, 1991; Phillips, 1996).  Phillips and colleagues (1996) 
have explored the hypothesis that early relationships with family, particularly one’s 
parents, may play a role in the etiology of BDD.  Utilizing the Parental Bonding 
Instrument, a measure of patients’ perceptions of parental care and overprotection, BDD 
patients in this sample reported lower scores of parental care as compared to published 
norms (Phillips, 1996).  
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 As previously discussed, several studies have noted that among BDD patients 
with social phobia, the social anxiety concerns predate the bodily preoccupation in the 
majority of patients (Wilhelm, et al., 1997; Phillips, et al., 1993; Gunstad & Phillips, 
2003).  Wilhelm and colleagues (1997) suggested that negative evaluation of the self in 
relation to other people (a core feature of social phobia) may predispose individuals to 
develop other self and appearance distortions characteristic of BDD.  However, this 
hypothesis warrants testing in future investigations.   
The developmental period of adolescence (the typical age of onset for this 
disorder) and its accompanying physical and psychological changes may play a role in 
the onset of BDD.  Adolescence is a time when relationships with peers become 
increasingly important.  It is also a time when physical changes in appearance may 
become more noticeable to others.  It has been hypothesized that added attention from 
others about appearance might play a role in the development of BDD, particularly if the 
attention is negative (Rosen, et al., 1995).  For example, teasing by one’s peers could 
cause an individual to question the normality of his appearance, even if it is not in fact 
deformed.  While these hypotheses are intriguing, more research is needed to clarify the 
role of social factors in the development of BDD.   
The influence of the media on the development of an ever more perfect beauty 
ideal is also thought to be a potential socio-cultural factor involved in the development of 
BDD.  In recent decades, there has been a substantial increase in the amount of coverage 
appearance receives in the media.  Society is bombarded with images of beauty ideals 
and messages regarding how to attain the ideal (Phillips, 1996; Sarwer & Crerand, 2004).  
This increased emphasis on physical perfection is hypothesized to be a potential factor in 
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the development of both general body image dissatisfaction as well as the appearance 
preoccupations among persons with BDD (Phillips, 1996; Heinberg, 1996; Sarwer & 
Crerand, 2004).  Specifically, it is thought that media images and messages reinforce the 
distorted beliefs that BDD patients hold (Phillips, 1996).  However, given the complexity 
of BDD, and the fact that it has existed for centuries prior to the increase in media 
attention on appearance, media messages are unlikely to be direct causative factors in the 
development of BDD.  However, they may play an important role in the maintenance of 
preoccupations with appearance.    
 Neurological theories.  Abnormal serotonergic function is thought to play a role 
in the development of BDD, as evidenced by the fact that patients seem to respond 
preferentially to SSRI medications (Hadley, Newcorn, & Hollander, 2002).  Additional 
evidence for the role of serotonin in BDD comes from neurochemical challenge studies, 
which have demonstrated that BDD symptoms tend to increase when patients are exposed 
to serotonin agonists (Hollander & Wong, 1995).  Treatment response studies have also 
revealed that dopamine may also play a role in the development of BDD (Hadley et al., 
2002).  Neuropsychological testing of patients with BDD has revealed deficits in verbal 
and nonverbal memory skills, as well as with organizational encoding abilities 
(Deckersbach, et al., 2000).  These impairments may be indicative of abnormalities in the 
frontal-striatal and dopaminergic systems (Hadley, et al., 2002).   
 Given the similarities of BDD to other obsessive-compulsive spectrum disorders 
(Phillips, et al., 1995), it is also hypothesized that anatomical regions of the brain 
implicated in OCD may also be involved in the development of BDD (Hadley, et al., 
2002).  For example, imaging of patients with obsessive-compulsive spectrum disorders 
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have shown hyperfrontality, increased caudate metabolism, and increased serotonergic 
sensitivity (Hollander, et al., 1993).  Dysfunction of the corticostriatal system, which 
regulates the processing and filtering of information and mediates repetitive automated 
behaviors, has also been implicated as a possible factor in the etiology of obsessive-
compulsive spectrum disorders (Hadley et al., 2002).  However, these findings need to be 
replicated in samples of patients with only BDD.  
2.6. Theoretical Issues 
 
Although classified as a somatoform disorder in the DSM-IV and a 
hypochondriacal disorder in ICD-10, there has been much debate among researchers 
regarding the proper diagnostic classification of BDD.  Many researchers purport that 
BDD is better classified as an obsessive-compulsive spectrum disorder (OCSD) (Phillips, 
et al., 1995).  OCSD is an umbrella term used to describe psychiatric disorders that share 
features with obsessive-compulsive disorder (OCD).  A disorder is considered a member 
of this spectrum if it is similar to OCD in terms of phenomenology, treatment response, 
comorbidity, family history, sex ratio, age at onset, course, and presumed etiology 
(Phillips, et al., 1995).    
There is much evidence to support the hypothesis that BDD is an OCD spectrum 
disorder.  Specifically, BDD and OCD share symptom similarities, preferential response 
to SSRI medications, similar neurobiological findings, and, as detailed above, high rates 
of comorbidity with each other and other disorders like depression and anxiety disorders 
(Phillips, et al., 1995).  Family history data suggests that OCD is the most common 
disorder in relatives of BDD patients (Hollander, et al., 1993).  There is also evidence to 
suggest that BDD occurs with greater frequency among first-degree relatives of patients 
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with OCD (Bienvenu, et al., 2000).  Additional support for this hypothesis is found in the 
similar age of onset, course, and sex ratios for these disorders (Phillips, et al, 1995).    
While BDD and OCD may share similarities, the defining difference is that the 
preoccupation and compulsive behaviors are centered on aspects of physical appearance.  
Additionally, BDD is associated with greater impairment than OCD as evidenced by the 
low rate of marriage among BDD patients and the greater frequency of comorbid social 
phobia in BDD sufferers (Phillips & Diaz, 1997; Phillips, Gunderson, Mallya, McElroy, 
& Carter, 1998).  The apparent similarities among these disorders has led some 
researchers (Phillips, et al., 1995; Hollander, Neville, Frenkel, Josephson, & Liebowitz, 
1992) to question the classification of BDD as a somatoform disorder, and to propose the 
reclassification of BDD as an anxiety disorder.  
 Researchers have also suggested that BDD may be a form of affective spectrum 
disorder (Hudson & Pope, 1990). Like OCSD, affective spectrum disorder is a term used 
to describe a family of disorders that share a common pathophysiologic abnormality 
(Hudson & Pope, 1990).  Disorders including bulimia, major depression and several 
anxiety disorders (OCD, GAD, panic disorder) have been grouped as affective spectrum 
disorders based on their response to antidepressant medications, common comorbidities, 
and family studies (Phillips, et al., 1995).  Unlike the OCSD categorization, the affective 
spectrum disorder classification hypothesis includes operationalized criteria, namely that 
the shared pathophysiology is evident in similar treatment responses, comorbidity, and 
family history studies.  Phillips and colleagues (1995) have argued that it is not 
unreasonable to include BDD in this family of disorders, based on the high rates of 
comorbidity of BDD with depression and social phobia, response to selective serotonin 
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reuptake inhibitors, and the high prevalence of major depressive disorder among relatives 
of BDD patients.   
In summary, the classification of BDD remains an issue of debate, although there 
is evidence to suggest that this disorder shares features of both obsessive-compulsive 
spectrum disorders and affective disorders.  However, research on the phenomenology of 
this disorder provides evidence that this disorder may be better classified under another 
diagnostic grouping, such as the anxiety disorders.  
2.7. Diagnosis and Assessment 
 
As noted above, the identification and diagnosis of BDD is difficult.  This is true 
not only within the mental health field, but also in disciplines like cosmetic surgery that 
encounter these patients frequently.  Diagnosis is further complicated by the fact that the 
majority of BDD patients do seek medical and not psychiatric treatments to ease their 
distress.  For example, diagnosis of BDD can be particularly challenging in cosmetic 
surgery practices, namely because of the objective of cosmetic procedures, which is to 
improve slight “defects” in appearance.  The judgment of any body feature as having an 
appearance “defect” is subjective.  Thus, in diagnosing BDD, the degree of emotional 
distress and behavioral impairment are thought to be more accurate indicators of the 
disorder among cosmetic surgery candidates (Sarwer, et al., 1998; Sarwer & Crerand, 
2003).   
Because a diagnosis of BDD is unlikely to be made unless the patient is asked 
specifically about the disorder and its symptoms, several self-report, diagnostic 
assessment tools have been developed to aid in the detection of BDD in clinical and 
medical populations.  
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Assessment Tools  
  The Body Dysmorphic Disorder Questionnaire (BDDQ), developed by Phillips 
(1996), is a brief, self-report measure which assesses appearance concerns and their 
impact on functioning in daily life.  Derived from DSM-IV diagnostic criteria, the BDDQ 
asks patients if their appearance concerns are sources of preoccupation and which body 
parts are of concern.  In order to obtain a positive screen, a person must indicate a 
preoccupation with a perceived appearance flaw and report moderate distress and/or 
impairment in functioning (Phillips, 1996).  This measure is intended as a screening tool, 
and not as a diagnostic instrument (Phillips, 1996).  A modified version of the BDDQ, the 
BDDQ-Dermatology Version has been recently developed (BDDQ-DV; Dufresne, 
Phillips, Vittorio, & Wilkel, 2001).   (See Method for further description of the BDDQ-
DV; See Appendix A for a copy of the BDDQ-DV)    
  Phillips and colleagues have developed a structured clinical interview known as 
the Body Dysmorphic Disorder Diagnostic Module (BDDDM; Phillips, 1996).  The 
format of this interview is similar to that used in the Structured Clinical Interview for 
DSM-IV (SCID), and the questions are based upon DSM-IV criteria for BDD.  The 
BDDDM has been shown to have excellent inter-rater reliability (kappa = .96) (Phillips, 
1996).  The BDDQ has been found to excellent agreement with the BDDDM (Phillips, 
1996; Dufresne, et al., 2001).  
The Body Dysmorphic Disorder Examination (BDDE) (Rosen & Reiter, 1996) is 
a 34-item semi-structured interview designed to assess for the presence and severity of 
BDD symptoms.  Specifically, this instrument assesses for preoccupation with and 
negative evaluation of appearance, self-consciousness, embarrassment, excessive 
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importance given to appearance in self-evaluation, avoidance of activities, body 
camouflaging, and body checking.  A self-report version has also been developed (Rosen 
& Reiter, 1996).  (See Method for further description; See Appendix E for copy of 
BDDE).  
2.8. Treatment 
  
 Pharmacological treatments for BDD typically involve the use of selective 
serotonin reuptake inhibitor (SSRI) antidepressant medications.  Psychological treatments 
most often utilize cognitive-behavioral techniques to address BDD symptoms.   
Pharmacotherapy.  Research on the pharmacological treatment of BDD is 
relatively new.  Case report studies have demonstrated the efficacy of SSRI 
antidepressant medications for the treatment of BDD in some patients (Phillips, 1998).  
For example, Hollander and colleagues reported a case series of 5 BDD patients who 
demonstrated a preferential treatment response for SSRIs (Hollander, Liebowitz, 
Winchel, Klumker, & Klein, 1989).  Studies which assessed treatment response also 
provided evidence for the efficacy of SSRIs.  Phillips and colleagues retrospectively 
assessed treatment response in 130 BDD patients, who collectively received 316 
medication trials.  Forty-two percent of the 65 SSRI trials resulted in symptom 
improvement, compared to 30% of 23 trials with monoamine oxidase inhibitors, and 15% 
of 48 tricyclic antidepressant trials (Phillips, 1996).  Another retrospective chart review 
study of treatment response among 90 BDD patients yielded similar results, with 65% of 
55 adequate SSRI trials resulting in symptom improvement (Phillips, Albertini, 
Siniscalchi, Khan, & Robinson, 2001).  
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Two open label studies have been conducted with fluvoxamine.  One study 
reported that 63% of their BDD patients responded to fluvoxamine (Phillips, Dwight, & 
McElroy, 1998).  Another investigation reported similar results with an open-label trial of 
fluvoxamine; two-thirds of the sample responded favorably to treatment (Perugi, 
Giannotti, Di Vaio, Frare, Saettoni, & Cassano, 1996).  Both studies, however, had small 
sample sizes. 
A 12-week, open label study has recently been conducted with another SSRI, 
citalopram (Phillips & Najjar, 2003).  Of the fifteen patients participating in this trial, 
73.3% responded to treatment, as measured by significant score decreases on the Yale-
Brown Obsessive Compulsive Scale Modified for BDD (YBOCS-BDD) and 
improvements in global functioning (Phillips & Najjar, 2003).  However, the small 
sample size and lack of a control group limit the significance of these findings.   
Hollander and colleagues (1999) conducted the first controlled pharmacotherapy 
trial (n = 40) for BDD.  Clomipramine, an SSRI, was found to be more effective than 
desipramine, a non-SSRI, with 65% responding to positively to clomipramine, compared 
to 35% responding to desipramine.  More recently, Phillips and colleagues have 
conducted a randomized, placebo controlled trial (n = 67) of fluoxetine for the treatment 
of BDD (Phillips, Albertini, & Rasmussen, 2002).  Results of this study suggest that 
fluoxetine treatment was significantly more effective than placebo, with 53% of the 
sample responding to fluoxetine, compared to 18% responding to placebo.  These studies 
suggest that SSRIs are potentially effective treatment options for BDD symptoms.   
Delusional variants of BDD appear to respond to SSRIs as well as the non-
delusional variant (Phillips, et al., 1998; Hollander, et al., 1999; Phillips, Albertini, & 
 
 
 
42
Rasmussen, 2002), whereas anti-psychotic medications have been shown to be ineffective 
for the treatment of both BDD variants (Phillips, et al., 1994).  There is some evidence to 
suggest that anti-psychotics may have some benefit when used in conjunction with SSRIs 
(Phillips, Albertini, Siniscalchi, Khan, & Robinson, 2001).  Higher doses and longer trials 
of SSRIs are often necessary to manage BDD symptoms (Phillips & Castle, 2002).   
More clinical trials including placebo controls are needed to further investigate the 
effectiveness of SSRIs in the treatment of BDD.  Further controlled trials are also needed 
to identify appropriate augmentation strategies and to investigate the effectiveness of 
other classes of anti-depressants medications and anti-psychotics in the management of 
BDD symptoms.    
Cognitive behavioral therapy.  Psychological treatments for BDD have also been 
investigated.  Preliminary research suggests that insight-oriented and supportive 
psychotherapy do not appear to be effective for the treatment of BDD (Phillips & Castle, 
2002).  Cognitive behavioral therapy, however, appears to be a more promising mode of 
treatment.   
Several investigations utilizing cognitive and behavioral techniques have reported 
favorable treatment responses for patients with BDD.  One study of 5 patients with BDD 
used a combination of exposure and response prevention techniques (i.e. exposing the 
defective body part in a social setting) and challenging the patients’ cognitive distortions 
(Neziroglu & Yaryura-Tobias, 1993).  This treatment strategy resulted in reductions in 
symptom severity for 4 out of the 5 BDD patients.  
Rosen and colleagues (1995) conducted a larger, randomized trial of cognitive-
behavioral therapy (CBT) for BDD.  Fifty-four patients were randomly assigned to either   
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CBT or a no treatment, wait-listed control group.  Therapy consisted of cognitive 
restructuring, along with exposure to avoided body image situations and the elimination 
of body checking (Rosen, et al., 1995).  Results indicated that 82% of patients in the 
treatment group achieved significant improvements in their BDD symptoms as compared 
to only 7% of patients in the control group. Furthermore, these effects were still noted at 
follow-up in 77% of treated patients (Rosen, et al., 1995).  
Similarly, Veale and colleagues (1996) conducted another study of CBT in 
nineteen patients with BDD who were randomized to either a CBT treatment or no 
treatment, wait-listed control group.  The CBT treatment group attained a 50% reduction 
in BDD and depression symptom severity at the end of treatment (Veale, et al., 1996).   
 Wilhelm and colleagues (1999) have reported similar successful findings for CBT 
in a study of 13 women with BDD.  After receiving CBT in a group format over 12 
weekly sessions, patients achieved significant improvements in BDD and depressive 
symptoms as assessed by the Yale-Brown Obsessive-Compulsive Scale modified for 
assessing BDD (BBD-YBOCS) and the Beck Depression Inventory (Wilhelm, Otto, 
Lohr, & Deckersbach, 1999).   
A recent review of randomized clinical trials for the treatment of somatoform 
disorders (including BDD) found support for the efficacy of CBT for treating BDD 
(Looper & Kirmayer, 2002).  While studies investigating CBT have yielded promising 
results, well-controlled studies and follow-up data are still needed to further evaluate its 
efficacy and ultimate effectiveness.  Although exposure and response prevention 
techniques have been utilized in most studies, the relative importance of this treatment 
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approach is unknown.  Additionally, no studies to date have evaluated the utility of 
combining CBT and pharmacotherapy.  Future studies are needed to address these issues.    
Non-psychiatric medical treatment.  Cosmetic surgical procedures are frequently 
the self-prescribed treatment of choice for individuals with BDD.  Among one sample of 
BDD patients, 70% (n = 188) had previously sought non-psychiatric treatments from a 
variety of medical specialists, including surgeons, dentists, and dermatologists, with 58% 
having received treatment (Phillips & Diaz, 1997).  An update on Phillips & Diaz’s 1997 
study found that among 250 adults with BDD, 76.4 % had sought non-psychiatric 
treatment, with 66% of this group actually receiving some form of treatment (Phillips, 
Grant, Siniscalchi, & Albertini, 2001).  The most common form of treatment received in 
this sample was dermatological (45.2 %), followed by cosmetic surgery (23.2%), with 
rhinoplasty being the most common type of surgery received (Phillips, et al., 2001).  
Approximately 35% of treatments requested were not received, and the most common 
reason for not receiving the treatment was physician refusal (Phillips, et al., 2001).     
Veale and colleagues (1996) reported that 48% of their sample (n = 50) had 
sought cosmetic or dermatological treatment at least once, and 26% had undergone one or 
more surgical procedures on their perceived defects.  Another study investigating the 
prevalence of BDD in a sample of 442 patients with a primary diagnosis of OCD 
determined that over half of those with BDD (57%; n = 20) had consulted plastic 
surgeons or dermatologists for treatment, and 15% had actually undergone plastic 
surgeries, with some patients reporting up to 6 surgeries on the same feature (Simeon, 
Hollander, Stein, Cohen, & Aronowitz, 1995).   
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The aforementioned studies, although not prevalence studies, speak to the rates at 
which patients with BDD seek medical treatment.  These statistics illustrate the need for 
assessment of BDD in medical populations, as patients tend to seek medical treatments 
for an undoubtedly psychiatric problem.  Surgeons performing facial procedures are 
likely to see an over-representation of individuals with this disorder, as the most common 
areas of concern involve the skin, nose and face (Phillips, et al., 1993; Phillips & Diaz, 
1997).   
Despite their insistence upon having cosmetic procedures, it appears that persons 
with BDD rarely benefit from these treatments.  Surgery frequently leads to an 
exacerbation of symptoms or the preoccupation may shift to another physical feature.  
Phillips and Diaz (1997) reported that 83% of procedures performed on BDD patients in 
their sample lead to an exacerbation or no change in BDD symptoms.  In their larger 
sample of BDD patients, Phillips and colleagues (2001) reported that the most frequent 
outcome (72% of cases) for non-psychiatric treatments was no change in overall BDD 
severity.  Even though 23% of treatments were found to result in decreased concern with 
the perceived defect, 68% of these treatments led to no improvement or worsening in 
overall BDD symptoms (Phillips et al., 2001).  The lack of improvement and/or 
worsening of overall symptoms was due to preoccupation shifts to other areas of the 
body, the development of new appearance concerns, or development of concerns that the 
treated area would become ugly again (Phillips, et al., 2001).   
Similarly, Veale and colleagues (1996) reported that among 25 BDD sufferers 
who underwent cosmetic surgery, 76% reported being dissatisfied with the postoperative 
result.  In addition, there is some evidence to suggest that these individuals may threaten 
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or take legal action against the surgeon, or become violent with the surgeon and his or her 
staff (Phillips, 1996; Sarwer, Crerand, & Didie, 2003).   
In summary, identification of patients presenting with BDD is a critical 
component of the psychological assessment of facial plastic surgery patients.  Persons 
with BDD frequently have unrealistic expectations for surgical outcomes, seeing surgery 
as a magical cure for all problems, and often demand additional surgeries on the same or 
different body features.  Recent studies suggest that persons with BDD do not benefit 
from cosmetic treatments, and often experience a postoperative exacerbation of their 
symptoms.  Although cosmetic treatments are unlikely to improve BDD symptoms, facial 
plastic surgeons are in an ideal position to identify and refer BDD sufferers for 
psychiatric evaluation and treatment. 
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3.  RATIONALE FOR CURRENT INVESTIGATION 
 
 
As described previously, the prevalence of BDD among patients seeking cosmetic 
procedures is not well known.  Sarwer and colleagues (1998) reported a rate of 7% in a 
cosmetic surgery population.  The study, however, had some methodological limitations.  
For example, the investigation lacked a control group.  Surgeons and nurses made 
informal ratings of appearance defects for patients who met criteria for BDD.  However, 
ratings for other patients in the sample were not provided.  Of the seven patients 
diagnosed with BDD in this sample, five were described as having defects that were “not 
observed” or “observed, although not unusual or abnormal” (Sarwer, et al., 1998, p. 
1647).  Two patients in their sample who met criteria for BDD had “more notable 
deformities of their respective features” (Sarwer, et al., 1998, p.1647).  Thus, the authors 
acknowledged that the 7% rate of BDD obtained might be inflated, given that two 
patients were concerned with features that were readily visible.  Additionally, surgeons’ 
judgments of slight or minimal deformity were used to help make a diagnosis of BDD.  It 
is possible that cosmetic surgeons, who are trained to identify and correct slight 
imperfections, may be more likely to under-diagnosis BDD in cosmetic patients.    
Phillips and colleagues (2000) reported a rate of BDD of 12% among patients 
seeking dermatological treatments.  This investigation also lacked an appropriate control 
group.  Furthermore, the measure used to assess BDD in this sample, the BDDQ-
Dermatology Version (BDDQ-DV), may have over-diagnosed BDD.  The BDDQ 
Dermatology Version has a limited positive predictive value (70%) as compared to a 
clinician-administered, semi-structured diagnostic interview (BDDDM; Phillips, 1996) in 
a dermatology setting, thus the BDDQ-DV may have overestimated the rate of BDD by 
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as much as 30% (Phillips, et al., 2000).  A smaller study that utilized this measure in a 
dermatology cosmetic surgery population found that it over-diagnosed BDD by 4% as 
compared to a brief, semi-structured interview (Dufresne, et al., 2001). 
 Measures based solely on DSM diagnostic criteria, like the BDDQ, have been 
criticized as being too vague (Fitts, et al., 1989).  Using the DSM-III-R BDD criteria in a 
sample of 258 college students, 70% of students reported some preoccupation with their 
appearance, while 28% endorsed all three diagnostic criteria (Fitts, et al., 1989).  The 
results of this study provide support for the contention that diagnostic criteria-based 
measures may over-diagnose appearance concerns.  However, DSM-III-R criteria for 
BDD did not include a requirement of impairment in functioning, therefore, the over-
estimation of BDD may not be as significant with measures based upon DSM-IV criteria.    
 Summarizing the results of these investigations, the rate of BDD in cosmetic 
surgery samples has not been firmly established.  Studies utilizing appropriate control 
groups and assessments which are able to distinguish between less severe body image 
dissatisfaction, thought to be a motivational component to cosmetic medical treatments 
(Sarwer & Crerand, 2003), and BDD are needed.  Additionally, studies that incorporate 
non-physician raters of defect severity may be able to more accurately capture the rate of 
BDD among patients seeking cosmetic procedures.   
 The present study is an attempt to address some of the methodological limitations 
of these studies and to further investigate the rate of BDD among patients who seek 
cosmetic procedures.  Given that most BDD patients report a preoccupation with facial 
features, this study specifically targeted patients seeking facial procedures.  In an attempt 
to identify the rate of BDD among other medical specialties that perform facial cosmetic 
 
 
 
49
surgery, an otorhinolaryngology clinic was included in this study.  Control participants, 
defined as patients presenting to these clinics for non-cosmetic procedures, were included 
in this study.  Patients’ areas of concern were rated for degree of severity by their treating 
physician, and a staff nurse, and a group of layperson raters.  Additionally, two measures 
of BDD, the BDDE-SR and the BDDQ-Dermatology Version, were used to account for 
the difficulties related to using a diagnostic-criteria based, self-report measure and to 
provide some data on the correspondence between the measures.  
3.1. Research Questions and Hypotheses 
 Hypothesis 1.  The primary aim of this study was to provide additional 
information on the rate of BDD among patients seeking cosmetic facial procedures. 
Patients who sought cosmetic facial procedures were predicted to have a higher rate of 
BDD than the rate obtained among patients seeking non-cosmetic procedures.  Rates in 
the range of 7 - 15% were expected among the cosmetic sample, as these are the rates 
obtained in previous cosmetic surgery settings.  The expected rate of BDD in the non-
cosmetic group was 2%, or the hypothesized rate of BDD in the general population.   
Hypothesis 2.  Correlates of BDD, namely body image dissatisfaction and 
depression, were assessed using the Multi-Dimensional Body Self Relations 
Questionnaire-Appearance Scales (MBSRQ; Cash, Winstead, & Janda, 1986; Brown, 
Cash & Mikulka, 1990) and the Beck Depression Inventory-II (BDI-II; Beck et al., 
1996).  The Body Dysmorphic Disorder Examination-Self Report (BDDE-SR; Rosen & 
Reiter, 1996) is primarily used to assess for the presence of BDD.  However, the total 
score obtained on this questionnaire provides a measure of body image dissatisfaction.  
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Higher levels of body image dissatisfaction and depressive symptoms were expected 
among patients who screened positive for BDD.  
Exploratory analyses.  An exploratory aim of this study was to determine if there 
was a difference in rates of BDD dependent upon which self-report measure was used to 
assess for its presence (BDDQ-DV vs. BDDE-SR).  As these are the only available self-
report screening questionnaires for the disorder, an investigation of the correspondence 
between these measures is needed in order to better understand differences in rates of 
BDD obtained in various studies.  It was hypothesized that more participants would meet 
criteria for BDD with the BDDQ-DV than with the BDDE-SR, as the BDDQ-DV is a 
diagnostic criteria-based measure that may be less stringent than the BDDE-SR which 
assesses specific behaviors associated with the disorder.  
A further exploratory aim was to determine if there are differences in severity 
ratings based upon type of rater (nurse, surgeon, or layperson raters).  Surgeons were 
expected to be more likely to rate the perceived defects of patients as being 
“present/noticeable” as compared to nurses and laypersons.  This hypothesis is based 
upon the fact that cosmetic surgeons are trained to notice even slight defects in 
appearance and to correct them using cosmetic medical treatments. 
It was hoped that exploratory analyses could be conducted to compare rates of 
BDD in a cosmetic surgery practice with those obtained in an otorhinolaryngology 
practice.  Exploratory analyses were also initially proposed to determine if there were 
differences in rates of BDD based upon the type of setting (university-based clinic versus 
community practices).  The otorhinolaryngology and community practices were unable to 
recruit large numbers of participants.  Therefore, the percentage of patients screening 
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positive for BDD at each site was calculated although not statistically tested, since these 
analyses would have been underpowered to detect differences between the practices.   
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4.  METHOD  
4.1. Participants  
One hundred forty-one patients participated in this study.  Three sites provided 
participants: 1) Four plastic surgeons (Drs. Scott Bartlett, Donald LaRossa, David Low, 
and Linton Whitaker) from the Division of Plastic Surgery at the University of 
Pennsylvania School of Medicine; 2) Dr. Daniel Becker, an otorhinolaryngologist at the 
University of Pennsylvania School of Medicine; and 3) Dr. Paul Glat, a plastic surgeon 
with a suburban practice.  The majority of patients were recruited from the surgeons in 
the Division of Plastic Surgery - (80.1%); 9.9% and 10.6% of patients were recruited 
from the practices of Drs. Becker and Glat.  
Patients were considered eligible to participate if they were new patients (i.e., 
presenting for treatment with the surgeon for the first time), over the age of 18, and 
seeking cosmetic or non-cosmetic procedures of the face.  Exclusion criteria included 
seeking cosmetic or non-cosmetic procedures for areas other than the face (i.e., 
abdominoplasty) and being unable to read or understand English.  There were no 
exclusion criteria based upon race or gender.  All patients were asked to provide written 
consent prior to participating in this study.  Institutional review board approval for this 
study was obtained from both Drexel University and the University of Pennsylvania.   
4.2. Procedure 
Packets containing consent forms, demographic questionnaires, and measures (see 
description below) were provided to patients prior to their first appointment with their 
surgeon.  Patients seeking facial procedures (cosmetic and non-cosmetic) were identified 
from the schedules of participating physicians.  At the University of Pennsylvania sites, 
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packets were mailed to eligible participants approximately two to four weeks prior to 
their initial consultation.  This packet included a cover letter, signed by the principal 
investigator (CEC), a consulting psychologist (DBS) and the treating physician.  Patients 
were provided with no incentive for participating.  At the community private practice 
setting, support staff and the treating surgeon recruited potential participants.   
Patients were instructed to return the packets to office staff at the time of their 
initial consultation. Of the 820 patients eligible to participate, 82% (n = 676) attended 
their scheduled appointments.  Of those who attended appointments, 21% (n = 141) 
completed packets.  Seventy-five percent did not respond to the request to participate.  
The remaining four percent of patients indicated that they were not interested in 
participating.  
The treating surgeon and his nurse were asked to complete a Defect Rating Scale 
(see Measures section below) after meeting with a given patient in order to obtain a 
measure of defect severity that is necessary for the diagnosis of BDD.  The nurse’s rating 
was included to assess if surgeons may be more likely to rate slight defects in appearance 
as more severe or noticeable.   
During the course of their initial consultations, most patients (83%) had 
photographs taken of their face.  Sixteen patients (11%) did not have photographs taken 
either because the surgeon deemed photographs to be unnecessary (as in the case of a 
patient who was having skin cancer lesions removed) or because the patient did not 
consent to having photographs taken.  Thus, defect ratings were not available for these 
patients.  Defect ratings were not obtained for 10 additional patients (7%).  Ratings were 
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not collected in these instances because surgeons and nurses forgot to obtain ratings, and 
in two cases, the patients completed packets but failed to show for their appointments.  
A sub-sample (n = 52) of patient photographs was also rated by a group of 
laypersons (n = 21).  These laypersons were recruited from the staff of the Weight and 
Eating Disorders Program at the University of Pennsylvania and from the undergraduate 
psychology class instructed by Dr. David Sarwer.  These ratings allowed for an additional 
assessment of the potential difference in ratings from medically trained and non-
medically trained persons.   
The medical charts of patients who completed packets were reviewed by CEC in 
order to verify the treatment as either cosmetic or non-cosmetic.  Ninety-one patients who 
completed packets sought cosmetic procedures.  Patients were classified as “cosmetic” if 
they sought a procedure because of dissatisfaction with their appearance unrelated to a 
medical condition or illness.  Examples of cosmetic facial procedures include 
rhytidectomy (facelift), botulinum toxin type A (Botox®) or calcium hydroxylapatite 
(Radiance®) injections for facial wrinkling, brow/forehead lifts, blepharoplasty 
(correction of sagging eyelids), rhinoplasty, and chin augmentation.  Table 1 provides a 
listing of procedures sought by the cosmetic sample. 
Fifty patients classified as seeking non-cosmetic procedures completed 
questionnaire packets and served as the comparison group.  Participants were classified 
as “non-cosmetic” if the procedure they sought was related to a medical illness or 
condition.  The term “non-cosmetic” is often used in clinical settings to designate 
reconstructive procedures that may be eligible for insurance reimbursement.  Non-
cosmetic procedures would include any facial surgical procedure performed for a medical 
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reason (e.g., blepharoplasty to remove drooping eyelid skin that causes vision 
impairment, lesion or mole removal), and not solely for an appearance reason.  Table 2 
provides a listing of non-cosmetic procedures sought by participants in this group, and 
Table 3 provides a description of the medical diagnoses represented in this sample.   
 
   
   
Table 1. Types of Cosmetic 
Procedures (N=91)  
    
Procedure Name   (%) 
    
Blepharoplasty   34.1 
Rhinoplasty   29.7 
Rhytidectomy   28.6 
Laser Treatment   16.5 
Browlift   15.4 
Fat injection   12.1 
Chin implants     7.7 
Submental Lipectomy    5.5 
Acne scar revision    4.4 
Radiance Injection    4.4 
Botox Injection     2.2 
Platysmaplasty     2.2 
Otoplasty     1.1 
Chin reduction     1.1 
Dermabrasion     1.1 
Laser hair removal    1.1 
 
Note: Percentages exceed 100% as some 
patients desired multiple  
procedures 
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Table 2. Types of Non-cosmetic* 
Procedures (N = 50)       
        
Procedure Name  (%)     
        
Laser Treatment  16      
Fat injections/grafts  16      
Scar Revision  14      
Nevus excision  14      
Septorhinoplasty  10      
Skin cancer excision 8      
Nerve graft 8      
Botox injections 6      
Zplasty  6      
Cranioplasty  4      
Reconstructive  4      
Browlift  2      
Lipoma excision  2      
Blepharoplasty  2      
Rhinoplasty  2      
Note: Percentage total exceeds 100 as some 
 patients sought more than one procedure 
 
*Non-cosmetic refers to procedures performed secondary 
to medical conditions or for reconstructive purposes 
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 Table 3. Non-Cosmetic Patient Diagnoses     
        
 Diagnosis       N %   
        
 Nevi    8 16  
 Scar revision (due to injury)  7 14  
 Cleft lip/palate revision   5 10  
 Deviated septum/Nasal deformity  5 10  
 Facial paralysis    5 10  
 Skin cancer    3   6  
 Burns    2   4  
 Port wine stains    2   4  
 Jaw reconstruction    2   4  
 Ptosis    1   2  
 Vascular malformations   1   2  
 Rhinophyma    1   2  
 Rosacea    1   2  
 Actinic keratosis    1   2  
 Hemifacial microsomia   1   2  
 Spider angioma    1   2  
 Lipoma     1   2  
 Facial atrophy    1   2  
 Eye socket reconstruction   1   2  
 Rohberg's disease    1   2  
_______________________________________________________________________ 
 
 
 
4.3. Measures (see Appendix for copies of each measure)  
Demographic Questionnaire.  Patients were asked to provide basic demographic 
information, such as their age, gender, race, marital and employment status, and 
education level.  Additionally, patients were asked to identify their current medications, 
referral source, length of time they had been considering surgery, whether they had 
undergone cosmetic surgery before (and if yes, how many times), what feature is to be 
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corrected, and whether this feature had been operated on before (if they answered yes to 
this question, they were asked to indicate the number of previous operations).  Patients 
were asked to indicate if they had experienced stress, depression, anxiety, or an eating 
disorder in the past year.  They were also asked to report if they had sought help from a 
mental health professional and/or physician for stress, depression, anxiety, or an eating 
disorder over the past year.   
Body Dysmorphic Disorder Questionnaire- Dermatology Version (BDDQ-DV).  
The Body Dysmorphic Disorder Questionnaire (BDDQ-DV) is a brief self-report 
measure which assesses appearance concerns and their impact on functioning in daily life 
(Dufresne, Phillips, Vittorio, & Wilkel, 2001).  This measure is a modified version of the 
Body Dysmorphic Disorder Questionnaire (BDDQ; Phillips, 1996).  The difference 
between the BDDQ-DV and the original BDDQ is that Likert scales have been 
substituted for “yes/no” questions regarding functional impairment and distress.  Derived 
from DSM-IV diagnostic criteria, the BDDQ-DV asks patients if their appearance 
concerns are a source of preoccupation and if so, which body parts are of particular 
concern.  Additional “yes/no” questions assess the degree to which appearance 
preoccupations have caused distress or interfered with the person’s social life and 
academic/occupational functioning, or resulted in avoidance of people and situations 
(Phillips, et al., 2000).  A positive screen for BDD is obtained if a patient acknowledges a 
preoccupation with appearance and at least moderate (Likert scale rating of 3 or above) 
distress or impairment in functioning related to such preoccupation.   
The BDDQ has a reported sensitivity of 100% and a specificity of 89%, as 
measured in a sample of 66 psychiatric patients (Phillips, 1996).  In a dermatological 
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cosmetic surgery setting, the BDDQ-DV had a reported sensitivity of 100%, specificity 
of 95%, positive predictive value of 70%, and negative predictive value of 100% 
(Dufresne, et al., 2001).  The sensitivity and specificity data for the BDDQ and BDDQ-
DV were obtained by comparing positive scores on these measures with the “gold 
standard” for BDD diagnosis, a semi-structured, clinician-administered, reliable 
diagnostic instrument (Body Dysmorphic Disorder Diagnostic Module (BDDDM; 
Phillips, et al., 2000, p. 437).     
Body Dysmorphic Disorder Examination-Self Report (BDDE-SR).  The BDDE-
SR is a self-report measure that assesses for the presence of BDD symptoms and body 
image dissatisfaction (Rosen & Reiter, 1996).  Patients are asked to rank five bodily 
features with which they are most dissatisfied.  Then, keeping in mind the body part with 
which they are most dissatisfied, patients answer a series of questions that assess 
preoccupation with the body part, negative evaluation of appearance, excessive 
importance of appearance in self-evaluation, avoidance of activities and places, and body 
camouflaging.  For the purposes of this study, participants were asked to rate only the 
feature(s) for which they were seeking surgery.  Specific items directly reflect DSM-IV 
criteria for the diagnosis of BDD.  These items assess for the presence of distress as well 
as for the frequency of behaviors associated with appearance preoccupations.  Higher 
scores indicate greater body image dissatisfaction.  Higher scores on the items thought to 
reflect DSM-IV criteria suggest the presence of BDD (see Table 4).  Adequate internal 
consistency and test-retest reliability have been established (Rosen & Reiter, 1996).  The 
self-report version has acceptable agreement with the interview version of this measure 
(BDDE) (Rosen & Reiter, 1996).     
 
 
 
60
 
      
      
Table 4. BDD Items on the BDDE-SR    
      
Criteria               Item # 
      
Preoccupation with appearance    
      
 How often have you thought about appearance and felt distressed 6
      
 How often have you worried about your appearance in public places 7
      
 How often have you worried about your appearance with friends, family 8
      
 How important is your appearance to your self-evaluation 12
      
 How negative are your thoughts about yourself due to appearance 13
      
Distress or Impairment    
      
 How upset do you become if someone notices or pays attention to appearance                9b 
      
 How much have you avoided public areas because of appearance 17
      
 How much have you avoided work or other social situations 18
      
 How much have you avoided close contact with others 19
      
  How much have you avoided physical activities  21
 
 
 
Defect Rating Scale.  The severity of the patient’s feature of concern was rated by 
treating physicians, nurses, and non-medically trained raters on a Likert scale, anchored 
by 1 (“none”) to 5 (“severe defect present”) (Phillips, et al., 2000).  This rating scale has 
been shown to have good inter-rater reliability (ICC = .88) (Phillips, et al., 2000).   
Multidimensional Body-Self Relations Questionnaire-Appearance Scales 
(MBSRQ-AS).  The MBSRQ-AS is a self-report measure designed to assess attitudinal 
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dispositions towards body image (Cash, Winstead, & Janda, 1986; Brown, Cash, & 
Mikulka, 1990).   This measure is a shortened form of the 69-item MBSRQ version. The 
Appearance Scales version consists of 36 items with five subscales: Appearance 
Orientation, Appearance Evaluation, Overweight Preoccupation, Self-Classified Weight, 
and Body Areas Satisfaction.  Individuals are asked to rate questions on a scale from 1 
(“definitely disagree”) to 5 (“definitely agree”).  Higher scores indicate greater 
satisfaction with body image.  Normative data has been obtained for this measure from a 
large random sample (n = 30000) (Cash, et al., 1986).  Adequate psychometric properties 
have been reported for this measure (test-retest reliability r = .91; internal consistency r = 
.88); factor analysis studies have demonstrated the stability and validity of the subscales 
(Brown, et al., 1990).  For the purposes of this study, the Appearance Orientation, 
Appearance Evaluation, and the Body Areas Satisfaction subscale items were analyzed 
and reported.  
Beck Depression Inventory II (BDI-II).  The BDI-II is a 21-item self-report 
measure which assesses the presence and severity of depressive symptoms based upon 
DSM-IV diagnostic criteria (Beck, Steer & Brown, 1996).  Each item consists of a list of 
four statements arranged according to increasing severity about specific depressive 
symptoms.  Individuals are asked to rate depressive symptoms over a time frame of the 
previous two weeks.  Psychometric analyses of the BDI-II indicate high levels of internal 
consistency (coefficient alpha = .92) and test-retest reliability (r = .93) (Beck et al., 
1996).  Convergent and factorial validity have also been demonstrated (Beck et al., 
1996).  Scores range from 0 to 63, with higher scores reflecting more severe depressive 
symptoms (Beck et al., 1996).   
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5.  STATISTICAL ANALYSES 
Power.  A sample size of one hundred sixty had been proposed in order to obtain 
enough statistical power to detect a difference in the rates of BDD between the cosmetic 
and non-cosmetic groups (power = .80, alpha = .05; Power and Precision Calculator©; 
Borenstein, Rothstein, & Cohen, 1997).  This power analysis was based upon the 
estimated frequencies of BDD obtained in cosmetic settings using similar methodologies 
(12%; Phillips, et al., 2000) and the general population (2%; Bienvenu, et al., 2000).  
Because of several recruitment problems, only one hundred forty-one patients 
participated in this study.  As a result, the power available for the main analysis was 
reduced to .60 (alpha = .05).   
Demographic variables.  Frequencies and means (with standard deviations) were 
calculated for demographic variables.  Independent t-tests and chi-square statistics were 
used to determine differences on demographic variables among cosmetic and non-
cosmetic patients and between patients screening positive for BDD and those who did 
not.  The p < .05 significance level was utilized for these tests.   
Rate of BDD.   The percentage of participants screening positive for BDD (based 
upon score on the BDDQ-DV, in combination with a surgeon rating of minimal or no 
deformity) was calculated for the cosmetic and non-cosmetic groups.  The BDDQ-DV 
was selected as the primary diagnostic measure of BDD for this study for two reasons.  
First, this measure is based on DSM-IV diagnostic criteria for BDD.  Second, since the 
design of the present study was based upon Phillips and colleagues (2000) investigation 
of the rate of BDD in a cosmetic dermatological setting, use of this measure facilitated 
comparisons between the rates of BDD determined in each study. 
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On the BDDQ-DV, positive scores were indicated by answers of “yes” to being 
preoccupied by appearance concerns (question 2), as well as a report of moderate distress 
or impairment in functioning (as indicated by a score of 3 or higher on questions 5 and/or 
6).  Participants who responded “yes” to having had an eating disorder over the past year 
on the Demographic Questionnaire and participants who described weight preoccupations 
on the BDDQ-DV were excluded from analysis.  The eating disorder and weight/shape 
concerns exclusions were made to satisfy the third diagnostic criterion for BDD, which 
states that the preoccupation with appearance is not better accounted for by an eating 
disorder or preoccupation with weight or shape (APA, 2000). This scoring procedure is 
consistent with that used by Dufresne and colleagues (2001). 
Pearson’s chi-square statistic was used to determine comparisons of BDD rates in 
cosmetic versus non-cosmetic patients. The p < .05 significance level was utilized for this 
test.  
Depression and body image dissatisfaction.  Mean scores and standard deviations 
for the overall sample on the BDI-II, MBSRQ-AS subscales, and BDDE-SR (total score) 
were calculated. The means on these measures for cosmetic and non-cosmetic patients 
and BDD and non-BDD patients were compared via independent samples t-tests.  
Bonferroni’s correction was used to prevent inflation of the type I error rate due to 
multiple tests on the three subscales of the MBSRQ-AS.  Thus, the p value was set at .02 
for analyses on this measure (i.e., .05/3 = .02).  The p < .05 significance level was 
utilized for the BDI-II and BDDE-SR analyses. 
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Exploratory Analyses 
Exploratory analyses were conducted to address the following issues: the rate of 
BDD as measured by the BDDE-SR, the diagnostic correspondence between the BDDQ-
DV and the BDDE-SR, and changes in the rate of BDD on the BDDQ-DV dependent 
upon rating scale cut-point and type of rater (surgeon or nurse).  Further exploratory 
analyses were conducted in order to determine if there was a difference in defect rating 
scores for surgeons, nurses, and layperson raters on a sub-sample of patient photographs.   
Finally, exploratory analyses of the rates of BDD in the community private practice and 
the otorhinolaryngology samples were conducted. 
Rate of BDD using the BDDE-SR.  The percentage of cosmetic and non-
cosmetic participants who screened positive for BDD on the BDDE-SR was calculated 
with and without surgeon ratings of minimal or no deformity.  These analyses were 
conducted in order to compare the rate of BDD obtained on this measure with the results 
of Sarwer and colleagues (1998) study, which used the BDDE-SR to diagnose BDD but 
did not incorporate defect ratings.   
 Participants were instructed to complete the BDDE-SR with respect to the facial 
feature for which they were seeking treatment.  Positive scores for BDD were determined 
by a score of 4 or higher on the items listed in Table 5.  These scoring strategies reflect 
the recommended scoring guidelines (Rosen & Reiter, 1996).   
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BDDQ-DV vs. BDDE-SR. The percentage of patients who were rated as having 
BDD on both measures was calculated.  Pearson’s chi square statistic was used to 
compare BDD rates obtained using the BDDQ-DV versus the BDDE-SR.  The p < .05 
significance level was utilized for this test.   
Defect ratings.  Because the third anchor on the rating scale (“present/clearly 
noticeable”) is somewhat vague in terms of defining defect severity, rates of BDD using 
the BDDQ-DV were also calculated using a surgeon defect rating of 3 or less.  Finally, 
rates of BDD were calculated using the BDDQ-DV and the defect severity ratings of 
nurses.   
Inter-rater reliability.  A sub-sample of photographs of participating patients (n = 
52) was rated by a group of objective raters (i.e., non-medically trained research 
assistants and students).  The inter-rater reliability of the defect severity scale was 
assessed by calculating the intraclass correlations (ICC) for the groups of raters on the 
sub-sample of photographs.  The ICC statistic was also calculated using the ratings of the 
surgeons and nurses for the entire sample.   
Private practice and otorhinolaryngology rates of BDD.   Percentages of patients 
screening positive for BDD in the community private practice and otorhinolaryngology 
practice were also calculated.  As with the cosmetic and non-cosmetic BDD rate 
determinations, the BDDQ-DV was used in conjunction with a surgeon severity rating of 
none or minimal/slight for these analyses.   
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6.  RESULTS 
6.1. Overall Sample 
Demographic variables.  The mean age of the overall sample was 44.79 ± 14.88 
years; 83% of participants were female. The majority identified their racial background 
as Caucasian (89%).  The sample averaged 15.47 ± 2.65 years of education and 
approximately two-thirds (69%) were employed.  Participants had considered surgical 
treatment for an average of 3.80 ± 6.12 years.  Nearly 43% (n = 60) reported prior 
cosmetic surgery, with an average of 2.16 ± 2.39 previous surgeries.  Table 5 provides 
further demographic information about the entire sample.  Table 6 provides further 
surgical history information about the entire sample.  
Thirty-one percent of patients also reported receiving mental health treatment in 
the past year.  Of those taking prescription medications, 31% (n = 30) reported taking 
anti-depressants, and 4% (n = 4) reported taking anti-anxiety medications.   
Depression and body image dissatisfaction.  Table 7 describes the mean scores 
on the BDI-II, MBSRQ-AS, and the BDDE-SR total scores for the entire sample.   
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Table 5. Demographic Characteristics      
       
Variable   Total Sample   Cosmetic   Non-Cosmetic
       
Age (M, SD)  44.79 (14.89)  46.69 (14.21)  41.34(15.61) 
       
Years of Education (M, SD)  15.48 (2.65)  15.79(2.64)  14.92(2.60) 
       
Gender (%)       
 
Female  83  90  70 
Male  17  10  30 
       
Marital Status (%)       
 
Married  43  48  34 
Single  31  28  38 
Divorced  11  9  14 
Living with partner  5  8  0 
Widowed  5  6  4 
Separated  5  2  10 
       
Race (%)       
Caucasian  89  95  80 
African American  6  4  8 
Hispanic  1  0  4 
Asian  1  1  0 
American Indian  1  0  2 
Other  1  0  4 
       
Employment Status (%)       
 
Full-time  56  63  44 
Part-time  11  11  10 
Retired  9  8  10 
Homemaker  8  10  4 
Student  7  6  10 
Disabled  6  0  16 
Unemployed  1  1  2 
______________________________________________________________________________________
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Table 6.  Surgical History         
 
          
Variable        Overall Sample Cosmetic   Non-Cosmetic
          
Have you had prior plastic surgery? (% Yes) 43%  48%  32%  
          
 Number of previous surgeries (M, SD) 2.17(2.39)  1.66 (1.11) 3.78 (4.17) 
          
Has this feature been operated on before? (% Yes) 31%  28%  36%  
          
 Number of previous surgeries (M, SD) 2.5(2.81)  1.78(.95)  3.47(4.03)  
          
Number of years considered having surgery  (M, SD) 3.80(6.12)  3.53(4.11)  4.35(8.89)  
          
Referral Source (%)         
          
 Self   40%  44%  32%  
          
 Another Doctor   29%  22%  42%  
          
 Another Patient   12%  15%  6%  
          
 Other   16%  17%  16%  
                     
 
 
          
Table 7. Depressive Symptoms and Body Image Dissatisfaction Scores (M, SD)    
          
Measure       Overall Sample Cosmetic  Non-Cosmetic 
         
BDI-II    8.95 (8.94)  7.64 (7.12)  11.64 (11.47) 
MBSRQ         
 
 Appearance Orientation 3.89 (.56)  3.97 (.46)  3.76 (.71) 
         
 Appearance Evaluation 3.22 (.81)  3.37 (.74)  2.96 (.87) 
         
 Body Areas Satisfaction 3.10 (.71)  3.19 (.66)  2.94 (.78) 
         
BDDE-SR (total score)  47.62 (31.04) 46.23 (28.42) 50.38 (35.91) 
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6.2. Cosmetic and Non-Cosmetic Groups 
Demographic variables.  Table 5 and Table 6 provide demographic and surgical 
characteristics for the cosmetic and non-cosmetic groups. The mean age of the cosmetic 
group was 46.69 ± 14.21 years.  The mean years of education was 15.79 ± 2.64; 63% 
were employed full-time, and nearly half (48%) were married.  The majority of cosmetic 
patients identified themselves as being Caucasian (95%).  Twenty-nine percent (n = 19) 
reported taking anti-depressant medication, whereas 2% (n = 1) reported taking anti-
anxiety medications.   
The mean age of the non-cosmetic group was 41.34 ± 15.61. The majority of non-
cosmetic patients identified themselves as Caucasian (80%), and 34% were married.   
Thirty-four percent (n = 11) reported taking anti-depressant medications, and 9% percent 
(n = 3) reported use of anti-anxiety medications.  Thirty-two percent reported prior plastic 
surgery, and 36% reported seeking surgery for a feature that had previously been treated.   
Non-cosmetic patients were significantly younger than cosmetic patients  
(t (139) = -2.07, p < .04).  Non-cosmetic patients were also more likely to be non-
Caucasian (χ² = 4.44, p < .04) and more likely to be unmarried than cosmetic patients  
(χ² = 7.12, p < .03).  Patients seeking non-cosmetic procedures had undergone a greater 
number of prior plastic surgeries (t (52) = 2.98, p < .004).  Cosmetic patients were more 
likely to be women (χ² = 5.23, p < .02) and they were also more likely to be employed  
(χ² = 5.24, p < .02) than non-cosmetic patients.  There were no significant differences 
between groups based upon other demographic variables, including medication usage, 
surgical history, or report of mental health treatment in past year. 
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Rate of BDD.  Three of the 141 patients in the entire sample indicated that they 
had been diagnosed with an eating disorder in the past year and were thus ineligible for 
the diagnosis of BDD.  All three of these patients were classified as non-cosmetic.  Eight 
patients (5 cosmetic, 3 non-cosmetic) reported weight/shape concerns on the BDDQ-DV 
and also were ineligible for the diagnosis.  Thus, of the original sample of 141 patients, 
130 were eligible for a BDD diagnosis.  
Using the BDDQ-DV and a surgeon defect rating of “none” or “minimal/slight”, 
7 of 91 cosmetic patients (8%) and 3 of 50 non-cosmetic patients (7%) met diagnostic 
criteria for BDD.  This difference in rates was not significant (χ² = .10, p < .75).  
In order to demonstrate the importance of incorporating a measure of defect 
severity, the rate of BDD was calculated using the BDDQ-DV without ratings.  The rate 
of BDD using the BDDQ-DV without any defect rating by the surgeon for the cosmetic 
group was 23.5% (n = 20).  For the non-cosmetic group, the rate of BDD was 38%  
(n = 17) when surgeon ratings were excluded.  The difference in rates was non-significant 
(χ² = 2.93, p < .09).  
BDDE-SR rate.  The rate obtained using the BDDE-SR (with surgeon defect 
ratings of none or minimal/slight) for the cosmetic group was 2% (n = 2) whereas the rate 
in the non-cosmetic group was also 2% (n = 1).  This difference was non-significant 
(Fisher’s Exact Test, p < .73).  When ratings were excluded, as is typically the case with 
the measure, the rate of BDD was 6% (n = 5) for the cosmetic group and 20% (n = 9) for 
the non-cosmetic group.  The rate obtained without ratings for the cosmetic group is 
consistent with the report of Sarwer and colleagues (1998).  The rate of BDD for the non-
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cosmetic group (without ratings) is slightly higher than the rate obtained by Sarwer and 
colleagues (1998) in their sample of reconstructive patients (16%).  
BDDQ-DV vs. BDDE-SR.  An exploratory aim of this study was to compare the 
rates of BDD obtained with the BDDQ-DV and the BDDE-SR.  When surgeon defect 
ratings (of none or minimal/slight) were combined with the BDDQ-DV, seven cosmetic 
and three non-cosmetic patients met criteria for BDD.  When the BDDE-SR was used in 
conjunction with surgeon ratings of none or minimal/slight, two cosmetic patients and 
one non-cosmetic patient met criteria for BDD. 
Of the seven patients meeting criteria for BDD in the cosmetic group, two (29%) 
patients met criteria on both measures.  Five patients (71%) met criteria on the BDDQ-
DV but did not meet criteria on the BDDE-SR.  None of the cosmetic patients met 
criteria on the BDDE-SR alone.  Among the three non-cosmetic patients, all three met 
criteria on the BDDQ-DV and did not meet criteria on the BDDE-SR.  Surprisingly, there 
was one non-cosmetic patient who met criteria on the BDDE-SR and did not score 
positively on the BDDQ-DV.    
As previously described, on the BDDE-SR, patients were required to obtain a 
score of four or higher on five of ten questions designed to assess for the first two 
diagnostic criteria for BDD (preoccupation with appearance and distress/impairment in 
functioning related to this preoccupation).  The five cosmetic patients and three non-
cosmetic patients did not meet criteria on the BDDE-SR because they did not report 
enough preoccupation or worry/embarrassment on the designated items and/or enough 
impairment in functioning.  Examination of these cases suggests that although both 
measures are designed to assess for the presence of BDD, the BDDE appears to have 
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more stringent definitions of preoccupation and impairment.  This difference in measures 
may account for the poor diagnostic correspondence between these measures.     
Of note, there was one non-cosmetic patient who met criteria on the BDDE-SR 
but not on the BDDQ-DV.  In examining this case, this particular patient did not indicate 
preoccupation with her appearance concerns on the BDDQ-DV, but did report moderate 
distress and moderate impairment in functioning.  
Chi square analyses were conducted to determine if there were differences 
between the cosmetic and non-cosmetic groups with respect to the endorsement of 
responses that are indicative of BDD (i.e., scores of 4 or higher) on the BDDE-SR.  
Bonferroni’s correction was used to prevent inflation of the type I error rate due to 
multiple tests on these ten items of the BDDE-SR.  Thus, the p value was set at .005 (i.e., 
.05/10 = .005).   
On Item 8 (“How much have you worried or felt embarrassed about your 
appearance feature when you were in social settings with coworkers, acquaintances, 
friends or family?”), non-cosmetic patients were more likely than cosmetic patients to 
endorse a rating of 4 or higher, indicating moderate to extreme amounts of worrying or 
embarrassment (χ² = 8.21, p < .004).  No other significant differences were found 
between the cosmetic and non-cosmetic groups on the BDD diagnostic items from the 
BDDE-SR.  
In summary, 29% (n = 2) of cosmetic patients met criteria on both measures, 
whereas 71% (n = 5) met criteria on the BDDQ-DV alone.   The difference in rates 
according to measure was significant for the cosmetic group (Fisher’s exact test, p < .01). 
Among non-cosmetic patients, all three met criteria on the BDDQ-DV alone.  However, 
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there was one patient who met criteria on the BDDE-SR and not on the BDDQ-DV.  The 
difference in rates according to measure was non-significant for the non-cosmetic group 
(Fisher’s Exact Test, p < .93).   Finally, on the BDDE-SR, non-cosmetic patients were 
more likely to report moderate to extreme worrying about their appearance as compared 
to cosmetic patients.   
Depressive symptoms.   The mean BDI-II scores and standard deviations for the 
cosmetic and non-cosmetic groups are listed in Table 7.  An independent samples t-test 
was used to determine if there were significant differences between the mean scores on 
the BDI-II for the cosmetic and non-cosmetic groups.  Because Levene’s Test for the 
equality of variance was significant, equal variances between groups cannot be assumed.  
This is not unexpected given the inequality of sample sizes (cosmetic vs. non-cosmetic).  
Results of the independent t-test (with equal variances not assumed) indicated that the 
non-cosmetic group had a higher mean score on the BDI-II as compared to the cosmetic 
group (11.6 ± 11.5 vs. 7.6 ±7.1; t (59) = 2.12, p < .04), suggestive of more depressive 
symptoms.   
As the non-cosmetic group was significantly younger than the cosmetic group, 
ANCOVA analyses were used to evaluate differences in means on the BDI-II while 
controlling for age.  Additionally, ANCOVA analyses were conducted using defect 
severity rating as a covariate in order to determine if defect severity was related to the 
mean differences obtained on the BDI-II.  Because Levene’s Test was significant for the 
analysis using age and defect severity as covariates, ANCOVA results are not reported, 
as this suggests that assumptions have been violated.   
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Body image dissatisfaction.  Mean scores and standard deviations for the 
cosmetic and non-cosmetic groups on the MBSRQ-AS subscales and the BDDE-SR are 
listed in Table 7.  On the Appearance Evaluation subscale, the mean score for the non-
cosmetic group was significantly lower as compared to the cosmetic group (2.96 ± .87 vs. 
3.37 ± .74; t (82) = -2.75, p < .007) indicating less satisfaction with overall physical 
appearance.  There were no significant differences between group means on the 
Appearance Orientation or Body Areas Satisfaction subscales or on the BDDE-SR.  
Several additional analyses were conducted using the BDDE-SR.  In order to 
determine if age or defect severity were related to the mean differences obtained on these 
measures, separate ANCOVA analyses were conducted using age and defect severity as 
covariates.  Because Levene’s Test was significant for the analysis using age as a 
covariate, ANCOVA results are not reported, as this suggests that assumptions have been 
violated.   
The group differences on the BDDE-SR were significant when controlling for 
defect severity (F (2, 116) = 92.73, p < .0001).  The adjusted mean score for the non-
cosmetic group was higher than the adjusted mean score for the cosmetic group (46.1 vs. 
42.1), suggesting more body image dissatisfaction among the non-cosmetic group.     
 Defect severity and pathology.  In order to determine if cosmetic and non-
cosmetic patients with more severe appearance defects experience more significant 
pathology (i.e., depression, body image dissatisfaction), the following analyses were 
conducted.  Rating scale scores were divided into two groups: minimal defect severity 
(rating scale score of 1 or 2) and noticeable/severe defect severity (rating scale score of 3, 
4, or 5).  This new severity variable was then used to predict differences on the BDI-II 
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and BDDE-SR in separate ANOVA analyses among the cosmetic and non-cosmetic 
groups.  In both groups, there were no significant differences between patients with a 
severity rating of 1 or 2 versus those with ratings of 3 or higher on both the BDDE-SR 
and BDI-II.    
6.3. BDD and Non-BDD Patients 
Demographic variables.  Table 8 provides the demographic description of the 
patients meeting criteria for BDD (using the BDDQ-DV and a surgeon rating of none or 
minimal/slight).  Of the ten people who met criteria for BDD in this sample, eight were 
female.  All 10 were Caucasian.  BDD patients were significantly younger than non-BDD 
patients (t (128) = 2.25, p < .03), with an average age of 34.60 ± 15.99.   They were also 
more likely to be seeking surgery for a feature which had previously been treated 
(Fisher’s Exact Test, p < .01).  Similarly, BDD patients reported having more previous 
surgeries on the feature for which they were currently seeking treatment (t (124) = -2.45, 
p < .02).  There were no other significant differences on demographic variables between 
BDD and non-BDD patients.   
Half of the BDD patients were single and two were married. Three BDD patients 
reported taking a psychotropic medication (antidepressant or anti-anxiety drug) and six 
reported having sought mental health treatment in the past year.  The majority (n = 6) was 
employed.  Table 9 describes the procedures sought by patients with BDD.  Of note, 
rhinoplasty was the most commonly sought procedure, with 4 patients requesting this 
type of surgery. 
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Table 8. Demographic Characteristics of BDD and Non-BDD patients    
       
Variable   BDD (n=10)   Non-BDD (n=120) 
Age in years (M, SD) 34.6 (15.99)  45.57 (14.75) 
Education-years (M, SD) 15.00 (1.56)  15.49 (2.78) 
Gender (n, %)     
 Female 8 (80%)   99 (83%) 
 Male 2 (20%)   21 (17%) 
      
Employment Status (n. %)     
 Full-time 5 (50%)   65 (55%) 
 Part-time 1 (10%)   14 (12%) 
 Homemaker 1 (10%)   10 (8%) 
 Retired 1 (10%)   10 (8%) 
 Disabled 0   7 (6%) 
 Unemployed 0   2 (2%) 
 Student 1 (10%)   9 (8%) 
      
Marital Status (n, %)     
 Married 2 (20%)   55 (46%) 
 Single 5 (50%)   37 (31%) 
 Divorced 1 (10%)   10 (8%) 
 Living with Partner 1 (10%)   5 (4%) 
 Separated 0   7 (6%) 
 Widowed 1 (10%)   6 (5%) 
      
Race (n, %)     
 Caucasian 10 (100%)   107 (89%) 
 African American 0   7 (6%) 
 Hispanic 0   2 (2%) 
 American Indian 0   1 (1%) 
 Other 0   2 (2%) 
      
Sought Mental Health Tx (n ,% yes) 6 (60%)   33 (28%) 
 Take antidepressants (n, % yes)  2 (20%)   24 (20%) 
 Take anti-anxiety meds (n,% yes) 1 (10%)   2 (2%) 
      
Surgical History     
 Prior cosmetic surgery (%yes) 6 (60%)   50 (42%) 
 Feature been treated before (%yes) 7 (70%)   32 (27%) 
 No. of previous feature surgeries (M, SD) 2.20 (2.90)  .65 (1.82) 
      
Type of Surgery     
 Cosmetic 7 (70%)   78 (65%) 
  Non-Cosmetic 3 (30%)     42 (35%)  
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Table 9. Types of Procedures Sought by BDD Patients (N = 10)   
       
       
Procedure Name   Cosmetic (n) Non-Cosmetic (n) 
       
Rhinoplasty  4  0  
Browlift   1  0  
Chin Implants  1  0  
Fat Injections/Grafts  1  2  
Cranioplasty scar revision 0  1  
       
Total     7   3   
  
 
        
        
Table 10. Depression and Body Image Dissatisfaction 
Among BDD (n = 10) and Non-BDD Patients (n = 120)   
        
Measure     BDD  Non-BDD             t                   p 
        
BDI-II (M, SD)  14.33(7.37) 8.36(8.46) -2.06 0.04 
        
BDDE-SR (Total Score, M, SD) 74.90(32.05) 46.14(30.42) -2.84 0.005 
        
MBSRQ-AS (M, SD)       
 Appearance Evaluation 2.81 (.87)  3.28 (.80) 1.76 0.08 
 Appearance Orientation 4.23 (.45)  3.86 (.57) -1.99 0.05 
 Body Areas Satisfaction 2.72 (.59)  3.16 (.72) 1.87 0.06 
      
 
 
Depressive symptoms.  Table 10 provides a listing of the means and standard 
deviations for the BDI-II scores of BDD and non-BDD patients.  An independent samples 
t-test indicated that the difference in means on the BDI-II for BDD and non-BDD patients 
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was significant (14.3 ± 7.4 vs. 8.4 ± 8.5; t (122) = -2.06, p < .042), with BDD patients 
reporting higher levels of depressive symptoms. 
Body image dissatisfaction.  Mean scores for the MBSRQ-AS subscales and the 
BDDE were compared via independent t-tests for participants who met criteria for BDD 
and for those who did not.  Table 10 provides a description of BDD and non-BDD mean 
scores on these measures.  On the MBSRQ-AS, BDD patients reported more unhappiness 
with their physical appearance as compared to non-BDD patients (Appearance Evaluation 
subscale); placed more importance on their appearance as compared to non-BDD patients 
(Appearance Orientation subscale); and reported lower satisfaction with several areas of 
their bodies as compared to non-BDD patients (Body Areas Satisfaction subscale).  
However, the differences between groups on each of these subscales only approached 
significance.    
On the BDDE-SR, BDD patients, as compared to non-BDD patients, had 
significantly higher scores (74.9 ± 32 vs. 46.1 ± 30.4; t (109) = -2.84, p < .005) 
suggesting more overall dissatisfaction with the feature for which they were seeking 
surgery. 
6.4. Exploratory Analyses   
Defect ratings.   To evaluate differences in the rate of BDD obtained when 
different rating cut-points were used, the rate of BDD was calculated when surgeon 
ratings of “present/noticeable” were included.  Using the BDDQ-DV and a doctor rating 
of 3 (present/noticeable) or less, the rate of BDD was 11%  (n = 9) for the cosmetic 
group, and the rate for the non-cosmetic group was 13.3%  (n = 6).  These rates suggest 
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that more patients would meet diagnostic criteria for BDD if a surgeon rating of 3 or less 
was used (See Tables 11 and 12).   
Nurse ratings.  Another exploratory aim of this study was to evaluate differences 
between nurses and surgeons in terms of their defect severity ratings.  It has been 
suggested that plastic surgeons may be more likely to under-diagnose BDD.  Their 
specialized training may lead them to see a slight defect as a correctable feature and not 
as a potential symptom of BDD.  Table 11 and 12 provide a listing of the rates of BDD 
obtained according to rater (surgeon and nurse) and cut-point on the Defect Rating Scale 
(ratings of none or minimal/slight vs. noticeable).    
When nurse ratings of none or minimal/slight were used in conjunction with the 
BDDQ-DV, the rate of BDD for the cosmetic group was 8.2% (n = 7), whereas none of 
the non-cosmetic patients met criteria for BDD.  Thus, the rate of BDD was identical for 
the cosmetic group as compared to when surgeon ratings of none or minimal/slight were 
used.  The finding that none of the non-cosmetic patients met criteria when the nurse 
ratings were included suggests that the nurses rated these patients as having more 
noticeable defects in appearance as compared to surgeons.   
When a nurse defect rating of 3 (present/noticeable) was used along with the 
BDDQ-DV, the rate of BDD in the cosmetic group was 12% (n = 10).  For the non-
cosmetic group, the rate of BDD using nurse ratings was 13% (n = 6).   
These findings suggest that overall, the surgeon and nurse defect severity ratings 
were similar for patients who met criteria for BDD on the BDDQ-DV.  The percentage of 
cosmetic and non-cosmetic patients who met criteria for BDD increased when ratings of 
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“noticeable/present” were utilized.  Of note, among non-cosmetic patients, nurses were 
more likely to rate patients as having more noticeable defects. 
 
 
        
Table 11. Percentage of Cosmetic Patients Meeting Criteria for BDD   
By Defect Rating Scale Level and Rater     
        
Type of Rater  Defect Rating Scale Level   
    None/Minimal (1, 2)   Present/Noticeable (3)  
        
Surgeon  8%   11%   
        
Nurse  8%   12%   
Note: Percentage reflects positive score on BDDQ-DV in conjunction with ratings 
 
 
        
Table 12. Percentage of Non-Cosmetic Patients Meeting Criteria for BDD   
By Defect Rating Scale Level and Rater     
        
Type of Rater  Defect Rating Scale Level   
        
    None/Minimal (1, 2)   Present/Noticeable (3)  
        
Surgeon  7%   13%   
        
Nurse  0%   13%   
Note: Percentage reflects positive score on BDDQ-DV in conjunction with ratings 
 
 
Inter-rater reliability.  In addition to collecting ratings from nurses and surgeons, 
a sub-sample (n = 52) of patient photographs was rated by a group of 21 female 
laypersons.  The degree of inter-rater reliability among the three rating groups for the 
sub-sample of photographs was assessed by calculating the intraclass correlation (ICC) 
statistic.  The ICC value when all three groups were included was .86, indicating 
adequate agreement on the defect rating scale between groups.  For the nurses and 
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surgeons, the ICC value was .84.  Similarly, the ICC value for the nurses and laypersons 
was .83.  For the layperson and surgeons, the ICC was .77, which is indicative of less 
agreement between these groups of raters.   From examining the frequencies of ratings 
for the surgeons and layperson raters on the sub-sample of photographs, 60% of the 
layperson ratings fell into the categories of “none” or minimal/slight.”  Among surgeons, 
none of the photographs received a rating of “none”, while 27% of the surgeon ratings 
fell into the “minimal/slight” category.  Thus, it appears the surgeons tended to rate 
patient defects as being more noticeable than the layperson raters.   
The ICC value for the nurse and surgeon ratings (based upon all ratings available 
for the sample) was .86, suggesting good agreement between nurses and surgeons with 
respect to ratings.  Of note, the ICC value obtained in this study is nearly identical to the 
value of .88 reported by Phillips and colleagues (2000).   
Private practice and otorhinolaryngology rates.  A final exploratory aim of this 
study was to report the rates of BDD in a community-based private practice and in an 
otorhinolaryngology clinic.  Fourteen percent of patients (n = 2) in the 
otorhinolaryngology clinic met criteria for BDD (based upon score on the BDDQ-DV 
and a surgeon defect rating of “none” or “minimal/slight”).  One patient sought 
rhinoplasty, whereas the other sought a browlift.  No patients from the community private 
practice met criteria for BDD.  However, the number of patients from each site is small, 
leading to concerns about the validity of these findings.   
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7.  DISCUSSION 
7.1. Review of Findings 
This study was designed to investigate the rate of BDD among patients who 
sought cosmetic facial procedures.  The rates of BDD in the cosmetic and non-cosmetic 
groups were nearly identical (8% vs. 7%).  As predicted, patients screening positive for 
BDD reported significantly higher levels of depression and body image dissatisfaction. 
There was a poor degree of diagnostic correspondence between the BDDQ-DV and the 
BDDE-SR, with only 29% (n = 2) of cosmetic patients meeting criteria on both measures.  
None of the non-cosmetic patients met criteria on both measures.  There were no 
differences in the rates of BDD obtained when nurse ratings were used instead of surgeon 
ratings among the cosmetic group.  However, when nurse ratings were used to calculate 
the rate of BDD in the non-cosmetic group, none of the patients met criteria.  Overall, 
there was good consistency between the nurse and surgeon ratings.  There was less 
consistency between surgeon and layperson ratings, as surgeons were less likely to rate 
appearance defects as “not visible” or “minimal/slight” as compared to layperson raters.   
Rate of BDD.  The rate of BDD obtained in this study for cosmetic patients (8%) 
is consistent with previous reports of BDD rates in cosmetic settings (7%; Sarwer at al., 
1998).  This finding is of interest given that the present study utilized the BDDQ-DV and 
Sarwer and colleagues (1998) used the BDDE-SR.  However, in the present study, when 
the BDDE-SR was used (in conjunction with surgeon defect ratings of “none” or 
“minimal/slight”), the rate of BDD in the cosmetic sample was only 2%, a rate that is 
lower than the 7% rate reported by Sarwer and colleagues (1998).    
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The discrepancy in rates between the present study and Sarwer and colleagues’ 
study may be related to several factors.  First, the present study used a formal rating 
scale.  Sarwer and colleagues used “informal” surgeon ratings of patient defects in their 
sample.  These informal ratings consisted of having the surgeon note whether the 
patient’s area of concern was “not observed”, “observed, although not unusual or 
abnormal”, or “more notably deformed” (Sarwer, et al., 1998, p. 1647).  Since two 
patients in their sample were rated as having notable deformities, the authors 
acknowledged that their reported rate of 7% might be inflated (Sarwer et al., 1998).  If 
these two patients were eliminated, the rate of BDD in their sample would then be 5%.   
The degree of correspondence between Sarwer and colleagues’ informal ratings 
and the rating scale used in the present study is unknown.  However, their rating category 
of “observed” appears to be similar to the Defect Rating Scale anchor of  “present/clearly 
noticeable.”  In the present sample, the rate of BDD among cosmetic patients increased to 
4% when a surgeon rating of “present/clearly noticeable” was used in conjunction with 
the BDDE-SR.  This result, although tentative, suggests that the difference in rates of 
BDD among cosmetic patients in these two samples may indeed be related to the rating 
scales used in each study.  Further investigation of the rate of BDD using the BDDE-SR 
and the Defect Rating Scale is warranted.   
Another possible reason for the discrepancies between the rate obtained with the 
BDDE-SR in the present study as compared to the rate in Sarwer and colleagues’ study 
may be related to the types of procedures sought by the patients in each investigation.  
Sarwer and colleagues (1998) included patients seeking cosmetic procedures for any 
body part, whereas the current sample was limited to patients seeking facial procedures.  
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While the literature suggests that the head and face are the most common areas of 
concern for patients with BDD, any part of the body can become an area of concern 
(Phillips & Diaz, 1997; Phillips, et al., 2001).  Therefore, the difference in rates could be 
related to the fact that Sarwer and colleagues did not limit their sample to facial 
procedures.     
The BDDQ-DV was selected as the primary diagnostic measure of BDD in this 
study in part so that a comparison could be made with the rate of BDD obtained by 
Phillips and colleagues (2000), as they used the BDDQ-DV and the Defect Severity 
Rating Scale to assess for BDD in their sample of cosmetic dermatology patients. The 
rate obtained in this study (8%) is lower than the rate of 12% obtained in Phillips’ report.  
The difference in rates could be related to differences in the types of patients studied in 
each sample (dermatology patients vs. facial cosmetic patients).  Phillips and colleagues 
(2000) also had a larger sample size (n = 268).  Despite these differences, the rate 
obtained in this study provides further evidence that BDD is not uncommon in settings 
that offer cosmetic medical treatments.   
BDDE-SR vs. BDDQ-DV.  An exploratory aim of this study was to compare the 
rates of BDD obtained when using the BDDQ-DV or the BDDE-SR.  Previous 
investigations of the rates of BDD in cosmetic settings have utilized either measure 
(Phillips, et al., 2000; Dufresne, et al., 2001; Sarwer et al., 1998) but no study to date has 
incorporated both measures.  In this study, only two of the seven cosmetic patients met 
criteria for BDD on both measures.  Similarly, none of the non-cosmetic patients met 
criteria on both measures.  Results from this study suggest that a higher percentage of 
participants met criteria for BDD according to the BDDQ-DV as compared to the BDDE-
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SR, a finding that was consistent in both cosmetic and non-cosmetic patients.  These 
results also suggest that there is poor diagnostic correspondence between the measures 
(29%).    
Reasons for the difference in rates obtained on each measure may have to do with 
the fact that the BDDE-SR quantifies impairment and distress in terms of how much time 
is spent worrying about appearance and how often activities are avoided.  Thus, the 
BDDE-SR assesses not only for the presence of distress or impairment in functioning, but 
it also provides a measure of the frequency and severity of these symptoms.  While the 
BDDQ-DV also assesses for severity of distress and impairment in functioning, 
frequency is not directly evaluated.  These distinctions between the measures may 
account for the differences in the rate of BDD obtained using the BDDQ-DV as 
compared to the BDDE-SR.   
Based upon this investigation, it is possible that the BDDE-SR is capturing more 
severe cases of BDD, whereas the BDDQ is sensitive to milder symptoms of BDD.  It is 
also possible that the BDDQ-DV may be overestimating the rate of BDD.  Phillips and 
colleagues (2000) have reported that the BDDQ-DV has a positive predictive validity of 
70% in a cosmetic dermatology setting to a brief, structured clinical interview, a finding 
that suggests that this measure may overestimate the rate of BDD by 30%.  Because the 
current study did not incorporate the use of a clinical interview, the predictive validity of 
the BDDQ-DV and the BDDE-SR in this sample is unknown.  Further comparisons of 
the rates obtained using each measure are needed, particularly with studies incorporating 
the use of a diagnostic clinical interview.  From a clinical perspective, use of the BDDQ-
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DV may be more appropriate in cosmetic surgery settings as it would be able to alert 
surgeons to the need for further assessment of a patient’s psychological health.     
Cosmetic vs. non-cosmetic patients.  It was hypothesized that the rate of BDD 
would be higher among patients seeking cosmetic procedures as compared to those 
seeking facial plastic surgery for non-cosmetic reasons.  This hypothesis was not 
supported, as the rates of BDD were similar in each group.  This finding was surprising, 
as the rate of BDD in the non-cosmetic group was hypothesized to be similar to the rate 
of BDD in the general population.  The non-cosmetic group was considered to be an 
appropriate comparison group because these patients were undergoing similar procedures 
to cosmetic patients but for primarily medical or reconstructive reasons.  The similar rate 
of BDD obtained in the non-cosmetic group suggests that the potential for body image 
distress among patients with disease or trauma related facial appearance concerns was 
underestimated.  Unfortunately, underestimation of the body image concerns of patients 
seeking medical treatment is quite common, even in settings that treat patients with 
largely visible disfigurements (Pruzinsky, 2004).   
Among patients with acquired or congenital disfigurements, the location of 
disfigurement is thought to play a role in how well an individual adjusts to appearance 
changes.  Pruzinsky notes that it is likely more difficult for patients with visible 
disfigurements (i.e., facial) to adjust to appearance changes as compared to those with 
disfigurements which are more easily camouflaged (i.e., bodily scars).  Thus, it is 
possible that the non-cosmetic patients were more likely to experience distress and 
impairment because their medical conditions or injuries affected their facial appearance.   
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However, it is important to note that there is no direct correlation between the 
extent of disfigurement and the degree of body image distress (Pruzinsky, 2002).  This is 
largely because body image is subjective in nature.  Therefore, it is possible for patients 
with minimal or slight disfigurements to report greater distress and impairment as 
compared to patients with objectively severe disfigurements.   
  The finding of a nearly identical rate of BDD between the non-cosmetic and 
cosmetic groups suggests that these patients are equally as likely to have appearance 
preoccupations and that the source of the appearance concern (e.g., medically caused or 
based purely on cosmetic concerns) may not be relevant.  These findings also confirm the 
subjective nature of body image dissatisfaction, in that heightened body image concerns 
may exist regardless of the cause or objective appearance of the perceived defect.   
While the cause of the appearance concern may not be relevant (e.g., a scar from 
acne vs. a scar from a lesion), the visibility and severity of the defect is critical to making 
a diagnosis of BDD.  Patients with visible defects, as in the case of patients seeking 
reconstructive procedures, would not be eligible for a BDD diagnosis.  However, those 
with minimal defects in appearance who experience disproportionate distress and 
impairment in functioning may indeed meet criteria for BDD.  
Of note, 38% (n = 17) of non-cosmetic patients reported symptoms consistent 
with BDD on the BDDQ-DV when ratings were not used.  When ratings were used, the 
rate of BDD in the non-cosmetic group decreased to 7%.  However, it is notable that 
nearly a third of the overall sample reported significant distress and/or impairment in 
functioning because of concerns with their appearance.  Given that this study included 
patients seeking reconstructive procedures for visible appearance concerns (i.e., burn 
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reconstruction, cleft palate revision), this rate is not entirely unexpected.  Sarwer and 
colleagues (1998) reported that 16% (7 of 43) of patients seeking reconstructive 
procedures reported significant distress and impairment in functioning related to their 
appearance.  They suggested that the distress and impairment reported by reconstructive 
patients might be indicative of underlying depressive or anxiety disorders (Sarwer, 
Whitaker, et al., 1998).    
At present, there is no diagnostic category in the DSM-IV TR that could be used 
to describe distress and impairment in functioning related to disfigurement.  As a means 
of capturing and validating the body image distress and dysfunction experienced by 
patients with visible as well as minimal or imagined appearance concerns, Thompson 
(1992) proposed criteria for a new diagnostic category, Body Image Disorder (BID).   
BID is defined as persistent dissatisfaction or concern with an aspect of physical 
appearance that results in distress and/or impairment in social or occupational 
functioning.  Two or more of the following criteria would also be required in order to 
receive a diagnosis of BID: 1) affective distress or anxiety experienced as a result of the 
appearance concern or exacerbation of distress in social situations; 2) appearance-related 
cognitive distortions which accompany distress; 3) avoidance of situations in which 
appearance evaluation by others may occur; 4) perceptual overestimation of body size 
(Thompson, 1992).  Furthermore, the proposed diagnostic criteria include specifiers to 
indicate the severity of the dissatisfaction (i.e., mild, moderate, severe); the visibility of 
the appearance concern (i.e., noticeable or imagined); and the target of the disturbance 
(i.e., weight/shape or specific body parts).  Such a diagnostic category would allow for a 
distinction to be made between BDD and those with appearance concerns related to 
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objective deformities, despite similarities in behavioral impairment and distress.  To date, 
BID has not been adopted as a diagnostic category within the DSM.  However, the 
findings of the present study provide support for the inclusion of such a diagnostic 
category in order to promote assessment of the body image concerns of patients with real 
and imagined appearance preoccupations.   
Although patients with visible appearance defects may experience symptoms 
similar to those that characterize BDD, it is inappropriate to diagnose them with BDD, as 
they do not meet the first criteria, namely that the appearance concern is imagined or 
slight.  However, it may be appropriate to use measures of BDD to assess for appearance-
related distress and impairment in functioning in order to fully capture the symptoms 
experienced by patients with visible appearance concerns.  Furthermore, cognitive-
behavioral treatments that have been developed to treat patients with body image 
concerns, including BDD, may also be appropriate interventions for patients with visible 
disfigurements.  The findings of the present study further highlight the need for the 
assessment of body image dissatisfaction and distress among patients seeking treatment 
for visible appearance defects.  Surgeons and nurses in cosmetic settings are in an ideal 
position to make referrals for psychological treatment for individuals experiencing 
appearance related distress and impairment in functioning (Sarwer et al., 1998). 
In addition to the underestimation of the appearance concerns of non-cosmetic 
patients, it is possible that the lack of difference in rates of BDD between the cosmetic 
and non-cosmetic groups is due to insufficient statistical power.  Due to slow recruitment 
and a low response rate, the number of participants included in this study was smaller 
than anticipated.  Recruitment was hampered by staff changes in the otolaryngology 
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practice and inconsistent enrollment at the private practice setting.  In general, the 
cooperation of staff members at all sites was less than ideal, in part because of their 
clinical demands.  These factors likely contributed to the smaller number of patients 
recruited for this study which subsequently limited the statistical power.  
Of note, the cosmetic and non-cosmetic groups differed on measures of body 
image satisfaction and depression.  Specifically, the non-cosmetic group reported less 
satisfaction with their overall appearance as compared to patients in the cosmetic group.  
The non-cosmetic group also reported more depression than the cosmetic group.  When 
defect severity was controlled, non-cosmetic patients had greater body image 
dissatisfaction as compared to cosmetic patients.  These findings may be related to the 
fact that the non-cosmetic group included patients seeking treatment for visible (and in 
some cases, severe) acquired or congenital defects in appearance.  Nearly 40% of the 
non-cosmetic patients received a surgeon or nurse defect rating of “moderately severe” or 
“severe”, suggesting that these patients had obvious appearance disfigurements.  This 
percentage is not surprising, given the medical diagnoses responsible for the defects in 
appearance.  For example, two patients who participated in this study were evaluated for 
reconstructive procedures secondary to severe facial burns, and another patient presented 
with a disfiguring hypertrophic port wine stain on his cheek and lips.  Furthermore, 10% 
of the non-cosmetic patients were seeking cleft-lip/palate revisions and another 10% 
sought treatment for facial paralysis.   
The higher levels of depression and body image dissatisfaction reported by non-
cosmetic patients may be indicative of distress and poor adjustment to the physical and 
psychological effects of the underlying medical condition.  These results are also 
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consistent with a previous study of the body image concerns of patients seeking 
reconstructive procedures for facial trauma.  Compared to age and gender–matched 
controls, facial reconstructive patients reported higher levels of depression and body 
image distress (Pruzinsky, 2002).   
 Demographic differences between the cosmetic and non-cosmetic groups may 
also provide an explanation for the higher rate of depression in the non-cosmetic group.  
For example, non-cosmetic patients were more likely to be unemployed as compared to 
the cosmetic group.  In fact, 16% of the non-cosmetic group reported their employment 
status as disabled.  Thus, it is possible that some of the non-cosmetic patients were 
experiencing health-related impairment in their everyday functioning, which in turn may 
contribute to depressive symptoms.  
In summary, the higher rates of depression and body image dissatisfaction found 
in the non-cosmetic group may be due to the severity and visibility of their appearance 
concerns.  The findings of this study suggest that individuals who seek treatment for 
appearance concerns related to medical conditions should also be screened for the 
presence BDD as well as body image concerns and depressive symptoms.  According to 
Pruzinsky (2004), the body image concerns of patients are often neglected by medical 
professionals, even among those patients with visible disfigurements.  These concerns 
can impair quality of life and cause significant suffering.  More studies of the body image 
concerns of patients with obvious appearance concerns are needed.  However, cosmetic 
surgeons may be in a unique position to treat the physical complaints of these patients 
and to identify those who may be in need of psychological treatment.  
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BDD vs. Non-BDD.  It was hypothesized that individuals screening positive for 
BDD would obtain higher scores on measures of depression and body image 
dissatisfaction.   BDD patients had significantly higher scores on the BDI-II than patients 
who did not meet criteria for BDD.  The mean score of 14.8 on this measure for patients 
with BDD suggests that their depressive symptoms were of mild severity.  The standard 
deviation of the BDD patient depression scores was 7.37, suggesting that a subset of 
these patients had depressive symptoms of moderate severity.  The higher level of 
depression reported among BDD patients is consistent with previous reports in the 
literature of the comorbidity of depression and BDD (Gunstad & Phillips, 2002; Phillips 
& Diaz, 1997).   
As expected, patients screening positive for BDD did report significantly more 
dissatisfaction with the feature for which they sought treatment as assessed by the 
BDDE-SR.  The mean score on the BDDE-SR for the BDD group was 75.91.  The 
standard deviation for the BDD group on the BDDE-SR was 30.59, suggesting that a 
subset of these patients had levels of body image dissatisfaction similar to those of 
patients seeking body image therapy (Rosen & Reiter, 1996).  On the MBSRQ subscales, 
patients screening positive for BDD reported greater investment in their appearance and 
less satisfaction with their overall physical appearance and with specific areas of their 
bodies as compared to patients who did not meet BDD criteria, although these differences 
were not statistically significant.  
Patients meeting criteria for BDD in this study were more likely to have had prior 
plastic surgery on the feature for which they were currently seeking treatment than those 
without BDD.  This finding is consistent with previous reports of BDD patients seeking 
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multiple cosmetic procedures in order to treat their appearance-related distress (Phillips, 
et al., 2001; Veale, 2000).  Similarly, BDD patients in this sample also reported a greater 
number of previous surgeries on the feature for which they were seeking treatment as 
compared to patients without BDD.  It is not uncommon for BDD patients to seek 
revisions of prior cosmetic procedures (Phillips, et al., 2001).  BDD patients were also 
significantly younger than non-BDD patients, a finding that is consistent with another 
study of the rate of BDD in a cosmetic dermatological setting (Phillips, et al., 2000).  
Similar to other reports, rhinoplasty was the most common procedure sought by patients 
with BDD in this sample (Phillips, Grant, Siniscalchi, & Albertini, 2001).  
Eight of the ten patients who met criteria for BDD in this sample were women 
(80%).  However, women were not significantly more likely to meet criteria for BDD as 
compared to men.  This finding is consistent with another study in which 75% of patients 
diagnosed with BDD were women, although women were not significantly more likely to 
meet BDD criteria in this sample either (Phillips, et al., 2000).  BDD is thought to affect 
men and women equally (APA, 2000; Phillips & Diaz, 1997; Phillips, et al., 2001).   
According to the American Society of Plastic Surgeons (ASPS), 85% of cosmetic surgery 
patients in 2002 were women.  The finding that more women met criteria for BDD in 
both of these samples may be due to the fact that generally more women present for 
cosmetic surgery as compared to men.   
In sum, the results of this study suggest that in cosmetic surgery settings, patients 
seeking surgery for features which have been previously treated and patients of younger 
ages may be more likely to present with BDD.  These demographic characteristics may 
serve as potential indicators of BDD in cosmetic settings.  Further research is needed to 
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determine the clinical characteristics of BDD patients who present for cosmetic 
treatment.  Patients presenting for cosmetic surgery, regardless of their demographic 
characteristics, should be screened for the presence of BDD given that they typically do 
not benefit from cosmetic surgery (Phillips, Siniscalchi, et al., 2001).  Furthermore, there 
is some evidence to suggest that patients with BDD may become violent toward 
themselves or the surgeon and his staff (Sarwer & Crerand, 2003).  Given the tendency of 
BDD patients to seek cosmetic cures for their psychiatric difficulties, surgeons are in an 
ideal position to identify patients with BDD. 
  Ratings.  Sarwer and colleagues (1998) have suggested that due to the 
subjectivity involved in rating an individual’s appearance, the degree of distress and/or 
behavioral impairment experienced by a patient may be more indicative of BDD.  This 
may be particularly true in cosmetic settings, where surgeons may be more likely to 
notice even slight appearance defects as a result of their specialized training.  This study 
incorporated nurse and layperson raters as a preliminary attempt to determine if there is 
evidence to support the hypothesis that surgeons are more likely to notice slight defects in 
appearance.  There was a good level of consistency between the surgeon and nurses on 
the defect rating scale.  Nurses and surgeons were more likely to rate appearance defects 
as being visible or noticeable as compared to laypersons.  The finding that nurses and 
surgeons made similar severity ratings of patient defects is not entirely surprising, given 
that the nurses in this sample have been working in a cosmetic setting for several years 
and may have become more aware of slight defects in appearance as a result of their 
experience.   
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There was less agreement regarding defect severity between laypersons and 
surgeons.  Laypersons were more likely to rate defects as being minimal/slight or not 
visible as compared to surgeons.  Thus, it is possible that as a result of their specialized 
training, surgeons are more likely to rate appearance defects as being more noticeable and 
to consequently under-diagnose cases of BDD.  Laypersons, such as office support staff, 
may be able to assist in the diagnosis of BDD in cosmetic settings as they may provide a 
more objective perspective on the appearance concerns of patients.  Furthermore, these 
findings suggest that surgeon ratings may differ from those of mental health professionals 
in diagnosing cases of BDD.  While these findings are intriguing, further investigation 
and replication are needed.     
The rate of BDD in this sample varied depending upon rater (nurse vs. surgeon) 
and cut-off point on the Defect Rating Scale.  These findings suggest that overall, the 
surgeon and nurse defect severity ratings were similar for patients who met criteria for 
BDD on the BDDQ-DV.  More cosmetic and non-cosmetic patients met criteria for BDD 
when ratings of “noticeable/present” were utilized.  Of note, among non-cosmetic 
patients, nurses were more likely to rate patients as having more noticeable defects.   
These findings suggest that even with use of a rating scale, there is still a certain degree 
of subjectivity inherent in evaluating appearance.  This subjectivity may be more 
pronounced when comparing types of patients or types of raters (e.g., surgeons and 
nurses) given that surgeons have more specialized training in detecting appearance 
defects.  
  A further issue related to the differences in rates of BDD obtained with different 
cut-points has to do with the Defect Rating Scale itself.  The middle item on the Defect 
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Rating Scale (“present/clearly noticeable”) seems to assess the visibility of the patient’s 
perceived defect as opposed to its severity.  This is potentially problematic when using 
such a rating to assess for the presence of BDD, given that it is possible for an appearance 
feature to be visible without necessarily being disfiguring.  A rating scale that 
incorporates a measure of both visibility and severity may be more appropriate for the 
assessment of BDD.   
 Psychiatric treatment.  Thirty-one percent of the overall sample reported having 
sought mental health treatment for anxiety or depression over the past year.  Thirty-four 
percent of the overall sample reported taking psychotropic medications (either anti-
depressants or anti-anxiety medications).  Among patients in the cosmetic group, 29% 
reported taking psychotropic medications, whereas 42% of the non-cosmetic patients 
reported use of these medications.  A recent study investigating psychiatric medication 
usage in a sample of patients seeking plastic surgery for cosmetic (n = 232) and non-
cosmetic reasons (n = 200) found that 18% of the cosmetic group reported taking a 
psychiatric medication at the time of their initial consultation (Sarwer, Zanville, LaRossa, 
Bartlett, Chang, Low, and Whitaker, in press).  Only 5% of the non-cosmetic patients 
reported taking a psychiatric medication at the time of their initial consultation (Sarwer et 
al., in press). 
The rate of psychiatric medication usage in the cosmetic group from the present 
study is higher than the rate reported in the Sarwer study.  It is possible that this 
difference is due to sampling method.  For example, Sarwer and colleagues used a sample 
obtained from a chart review, whereas the present study’s results are based upon a sample 
of volunteer participants.   
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The rate of psychiatric medication usage in the non-cosmetic group is strikingly 
higher compared to Sarwer and colleagues’ results.  One potential reason for this 
difference may be related to the types of procedures sought by the non-cosmetic patients 
in each sample.  In Sarwer and colleagues’ study, the majority of patients were seen for 
lesion removal.  In contrast, the non-cosmetic patients from the present study were 
seeking treatment for more noticeable appearance concerns, such as facial palsy or cleft 
palate revision.  Furthermore, the sample of non-cosmetic patients in the present study 
was limited to patients seeking facial cosmetic treatments.  The greater visibility and 
severity of the appearance concerns, in combination with the higher rates of depression 
and body image dissatisfaction found in the non-cosmetic group may account for the 
difference in rates of psychotropic medication usage in these two samples. 
The high rate of psychotropic medication usage among patients in this sample 
may have implications for the treatment of patients in cosmetic settings.  Sarwer and 
colleagues (in press) have suggested that psychotropic medication usage may be 
considered a “marker” of psychopathology.  A patient’s report of psychotropic 
medication usage may alert the surgeon to the need to gather further psychiatric history.   
Given the high comorbidity rate of anxiety and depressive disorders with BDD, patients 
presenting with psychiatric histories should be assessed for BDD symptoms.  While the 
use of psychotropic medications may provide an indication of the psychological health of 
a patient, screening for BDD should not be limited to those with psychiatric treatment 
histories, as many BDD patients do not seek psychiatric treatment as a result of their 
distress (Phillips, et al., 2001; Phillips & Diaz, 1997).  In the case of patients with 
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objective deformities, use of psychotropic medication may be an indicator of distress and 
impairment in functioning related to appearance concerns.       
7.2. Limitations  
The present study has several limitations.  First, the finding that only 21% of the 
eligible patients completed the packet suggests that there is some degree of selection bias 
present in this sample.  The study by Phillips and colleagues (2000) reported a 
participation refusal rate of 34%.  In that study, participants were recruited by on-site 
research assistants, suggesting that there may be other reasons aside from recruitment 
strategy that affect participation in studies of BDD.  Also, Sarwer and colleagues (1998) 
had a refusal rate of about 20%.  The higher refusal rate obtained in the present study 
may be due to a lack of participation incentives and the recruitment strategy utilized.   
Another factor that likely contributed to the low participation rate was that non-
cosmetic patients might have thought that the measures were irrelevant given the nature 
of their appearance issues.  This issue was specifically addressed in the cover letter sent 
to eligible patients, however, the impact of this is unknown.  Furthermore, the staff at the 
surgical practices did not participate in the recruitment of patients.  Changes in the 
support staff at the otorhinolaryngology clinic resulted in discontinuation of data 
collection for a period of time.  The recruitment of participants from the private practice 
was inconsistent.  As a result, the numbers of patients recruited from these settings was 
low, which subsequently prohibited a formal comparison of the rate of BDD in these 
settings.  
Finally, many individuals with BDD are reluctant to discuss their appearance 
concerns with others for fear of shame or ridicule (Phillips, et al., 1993; Veale, et al., 
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1996).  Individuals with BDD are known to persistently pursue cosmetic treatments. 
Thus, it is possible that patients with BDD declined to participate for fear of 
embarrassment or for fear of being prevented from having their desired surgical 
procedure.  
A second limitation of the present study is related to the fact that self-report 
questionnaires were used to assess for BDD symptoms, as well as symptoms of 
depression and body image dissatisfaction.  Although the measures utilized in this study 
have adequate psychometric properties, there is always the risk that participants answered 
questions in a socially desirable or otherwise biased manner.  The lack of use of a clinical 
interview to confirm the presence of BDD among patients who screened positive for this 
disorder is a further limitation.  A clinical interview, such as the SCID module for BDD, 
would have provided additional information on the comparison of hit rates on the BDDQ-
DV and the BDDE-SR.   
The inclusion of a measure of defect severity in this study was an improvement 
over prior studies investigating the rate of BDD in cosmetic settings.  The finding that 
surgeons and nurses were more likely to rate appearance concerns as noticeable as 
compared to layperson raters is intriguing.  However, methodological issues may limit 
the ability to generalize this finding.  For example, only a sub-sample of photographs was 
rated by laypersons in part because of the different ways each surgeon took and stored 
photographs (i.e., computerized photographs stored on CDs versus Polaroid photographs 
stored in charts or in slide versions).  Photographs were not available for some patients 
either because the surgeon deemed photos to be unnecessary or because the patients did 
not consent to have photographs taken.  An additional methodological weakness is that 
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some of the nurse and surgeon ratings were made from photographs, whereas other 
ratings were made at the patient’s initial consultation.  It is possible that photographs may 
not capture the extent of a patient’s appearance concern, particularly if the defect is only 
noticeable from certain angles.    
Furthermore, the validity of the rating scale is also questionable, as it is possible 
that surgeons may judge the appearance concerns of cosmetic patients differently than 
those of patients presenting for non-cosmetic treatment.  For example, one surgeon noted 
that he uses “a different scale in his mind” for assessing the severity of reconstructive 
patients’ appearance concerns as opposed to those of cosmetic patients.  He noted that it 
is assumed that there is a deviation from normality present in the non-cosmetic patient’s 
facial appearance.  The goal in treating acquired or congenital appearance defects is to 
make facial features appear more “normal,” whereas the goal for cosmetic procedures is 
often to improve an otherwise “normal” appearance.  Thus, a rating of “minimal/slight” 
for a non-cosmetic patient may in fact reflect a more noticeable, abnormal appearance 
concern as compared to the same rating given to a cosmetic patient wanting to improve 
an otherwise “normal” facial feature.   
Finally, demographic characteristics (such as the age or gender) of the raters may 
play a role in the defect severity rating given to patients who do not share the same 
demographic characteristics.  In this study, female college students and research 
assistants were used as layperson raters, a group whose mean age was considerably 
younger than the mean age for this sample of patients (22.05 ± 2.64 years vs. 44.79 
±14.89 years).  It is possible that younger raters or raters of different genders may rate 
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appearance concerns as more or less noticeable as a function of age.  The relationship 
between these variables requires further investigation.  
7.3. Future Directions 
 Further investigations of the rate of BDD in cosmetic settings are needed.  Future 
studies should incorporate the use of structured clinical interviews (such as the Body 
Dysmorphic Disorder Diagnostic Module (BDDDM; Phillips, 1996) or the Body 
Dysmorphic Disorder Examination (BDDE; Rosen & Reiter, 1996)) as well as self-report 
questionnaires in order to better estimate the rate of BDD in this population.  For 
example, patients could complete both the BDDE-SR and BDDQ-DV prior to their visit.  
A clinician (who is blinded to the patient scores on the BDDE-SR and BDDQ-DV) then 
could administer a structured clinical interview to assess for the presence of BDD. This 
design would allow for a more accurate assessment of diagnostic correspondence 
between the self-report measures as well as diagnostic confirmation should a patient meet 
criteria on one of the self-report measures.  An investigation of the degree of diagnostic 
correspondence between the self-report measures is needed, particularly in light of the 
poor rate of diagnostic correspondence between the BDDE-SR and BDDQ-DV found in 
this study.     
In the present study, patients reporting weight and shape concerns were 
eliminated from analyses of the rate of BDD.  Other studies investigating the rate of BDD 
have also excluded those with weight and shape concerns (e.g., Sarwer, Cash, et al., 
2004; Bohne, Keuthen, Wilhelm, et al., 2002, Cansever, et al., 2003).  The rationale for 
excluding patients with weight and shape concerns is related to the third diagnostic 
criterion for BDD, namely that the appearance concerns are not better accounted for by 
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the weight and shape concerns which often characterize eating disorders.  However, there 
has been little empirical investigation into the relationship between weight and shape 
dissatisfaction and other bodily appearance concerns.  There is evidence to suggest that 
BDD may co-occur with eating disorders at a higher rate than previously reported (Grant, 
et al., 2002).  Furthermore, in one of the largest studies of the clinical features of BDD 
patients, 20% of women and 8% of men reported weight concerns in addition to other 
appearance preoccupations (Phillips & Diaz, 1997).   
Thus, it may be premature to exclude weight and shape concerns in determining if 
patients meet criteria for BDD.  Specifically, studies examining the rate of BDD among 
patients with eating disorders, as well as studies investigating the occurrence of eating 
pathology and weight concerns among those with BDD would help to further evaluate the 
relationship between these disorders and the body image disturbances that characterize 
each.    
Future studies should also utilize strategies to limit selection biases in their 
samples.  For example, incorporation of the BDDQ-DV or BDDE-SR with the initial 
paperwork that patients are typically asked to complete while actually in the office may 
be a better strategy for studying the rate of BDD in this population.    
Studies investigating the rate of BDD among patients seeking non-facial cosmetic 
procedures are also needed, given that any part of the body can become an area of 
preoccupation for a person with BDD.  Furthermore, future studies should examine the 
rate of BDD among patients seeking specific procedures, such as rhinoplasty, considering 
that many BDD patients report preoccupations with their noses.   
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Although this study incorporated a small number of patients from an 
otorhinolaryngology clinic, the rate of BDD in this population has yet to be adequately 
investigated.  Studies should also be conducted in other settings, such as oral and 
maxillofacial surgical practices and orthodontic practices because of the growing number 
of cosmetic procedures performed by these specialists.  To date, the rate of BDD has 
primarily been investigated in university-based cosmetic practices.  Studies of the rates of 
BDD in community settings are needed in order to determine if there are differences in 
the rates dependent upon type of practice setting.   
   The present study attempted to improve upon previous investigations by 
incorporating a comparison group of patients seeking non-cosmetic procedures.  As 
previously noted, there were significant differences in depression and body image 
dissatisfaction between the non-cosmetic and cosmetic groups in this study.  
Furthermore, the rates of BDD between these two groups were nearly identical. These 
findings suggest that non-cosmetic patients may not have been the most appropriate 
patients to use as a comparison group.   
Additional studies utilizing more appropriate control groups are needed.  For 
example, a sample of individuals from the general population matched for gender and age 
may provide a more appropriate control group.  Age-matched control samples may be of 
particular importance, given that BDD patients in this sample were significantly younger 
than patients without BDD.  It may also be useful to match patients based upon 
procedure.  Controlling for these factors may facilitate more meaningful comparisons 
between patients with and without BDD.    
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A further strength of this study was the incorporation of a measure of defect 
severity, as well as the use of nurse, surgeon, and layperson raters.  However, the Defect 
Severity Scale utilized in this study appears to confuse the issue of visibility and severity 
on one of its items.  The development of a rating scale which measures both visibility and 
severity may be more useful in determining if a patient meets criteria for BDD.  While 
different raters were utilized in this study, differences in ages between the layperson 
raters and the patients in this sample may have biased the layperson ratings.  
Furthermore, the fact that some ratings were based upon photographs and others based 
upon “live” views of the patients’ defects, may have led to differences in ratings.  These 
methodological issues should be appropriately addressed in future studies.   
 In summary, the present study identified a BDD rate of 8% in the cosmetic group 
and a rate of 7% in the non-cosmetic group.  There was no difference between the rates of 
BDD obtained in the cosmetic sample as compared to the non-cosmetic group.  Patients 
who met criteria for BDD reported more depression and body image dissatisfaction, a 
finding that is consistent with the previous literature.  The rate of BDD varied depending 
upon which self-report measure was utilized, suggesting that these measures may be 
assessing different constructs (e.g., presence of BDD symptoms vs. severity of BDD 
symptoms).  Surgeons and laypersons differed in their ratings, with surgeons being more 
likely to rate the appearance concerns of patients as noticeable.  Together, these findings 
illustrate the need for assessment of BDD in among patients presenting to cosmetic 
settings, regardless of the reasons why they are seeking treatment.   
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APPENDIX A: Body Dysmorphic Disorder Questionnaire – Dermatology Version 
(BDDQ-DV; Dufresne, Jr., Phillips, Vittorio, & Wilkel, 2001) 
 
 
1.  Are you very concerned about the appearance of some 
     part of your body, which you consider especially unattractive?   YES      NO 
 
****************************************************************** 
 IF NO, THANK YOU FOR YOUR TIME AND ATTENTION.  YOU ARE    
 FINISHED WITH THIS QUESTIONNAIRE. 
 
2.    If yes, do these concerns preoccupy you? That is, you think  
       about them a lot and they are hard to stop thinking about?             YES       NO 
 
3. What are these concerns?  What specifically bothers you  
        about the appearance of these body parts? _________________________________________ 
       ______________________________________________________________ 
       
4.    What effect has your preoccupation with your appearance had on your life?  
_____________________________________________________________ 
 
5. Has your defect often caused you a lot of distress, torment, or pain?  How    
       much?  (Please circle the best answer) 
 
1  2  3  4      5 
     (No distress)   (Mild, and not        (Moderate and        (Severe, and           (Extreme, and  
     too disturbing)        disturbing but          very disturbing)      disabling) 
           still manageable) 
         
6. Has your defect caused you impairment in social, occupational, or other important areas of 
functioning?  How much?  (Please circle the best answer) 
 
1  2    3    4        5 
    (No limitation)       (Mild interference,    (Moderate,         (Severe, causes            (Extreme, 
                             but overall                  definite             substantial                   incapacitating) 
         performance not        interference,        impairment) 
         impaired)               but still  
                 manageable)  
 
              7.  Has your defect often significantly interfered with your social life?      YES  NO 
              7a.  If yes, how? ______________________________________________________________ 
                     
8. Has your defect significantly interfered with your school work,  
        your job, or your ability to function in your role?      YES  NO 
 
9.     Are there things you avoid because of your defect?     YES  NO 
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APPENDIX B: Defect Rating Scale (Dufresne, Phillips, Vittorio, & Wilkel, 2001) 
 
 
 
 
 
 
None  Minimal/Slight Present/Clearly  Moderately             Severe 
     noticeable at a      severe 
     conversational 
     distance 
(1)                           (2)         (3)                     (4)     (5) 
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APPENDIX C: Demographic Questionnaire 
 
 
Date of Birth: __  /__ /__ 
  
Gender:     Female Male 
 
Race:         Caucasian 
        African American 
        Asian 
        Hispanic 
        American Indian 
        Other 
 
Marital Status:  (circle best answer) 
   Single 
     Married 
   Living with partner 
     Separated 
     Divorced 
     Widowed 
 
Employment Status:   (circle best answer) 
Employed full-time  
   Employed part-time 
   Retired 
   Disabled 
   Homemaker 
   Student 
 
Educational Level (circle highest level completed) 
    
Less than High School 
   High School diploma 
   Associate degree 
   Vocational Training 
   Some college 
   College Degree 
   Graduate Degree 
 
Please list your current medications:  ________________________________ 
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Who referred you to this clinic?     Self   Other 
 (circle  all that apply)   Another physician 
      Another patient 
 
Have you ever had cosmetic surgery before?   YES NO 
If yes, how many times? ________________ 
 
How long have you considered having this current surgery? 
___________________________________________________ 
 
For what feature/body part are you seeking this current  
surgery?__________________________________________________________ 
 
Have you ever had this feature/body part operated on before?    YES NO 
If YES, how many times before? _____________________________________ 
 
Is your main concern with your appearance that you aren’t  
thin enough or that you might become too fat?        YES NO 
 
 
Within the past year, have you experienced….(circle all that apply) 
 
  Stress 
  Depression 
  Anxiety 
  Eating Disorder (anorexia, bulimia) 
 
Have you ever sought help from a mental health professional  
            and/or your physician for these issues?      
   
YES     NO 
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APPENDIX D: Body Dysmorphic Disorder Examination – Self Report  
(BDDE-SR; Rosen & Reiter, 1996). 
 
The following questions will ask you to think about your “appearance feature” – this refers to the body 
part you ranked as number “1” on the list of the previous page.  Answer according to the past four 
weeks.  To answer the questions, you may choose any number from 0 – 6, even if there is no description 
next to it.  Please circle only one number for each question. 
 
 
1. Over the past four weeks:  How common have you felt it is for people your age and sex to have an 
appearance feature just like the one you believe you have? 
0 everyone has the same feature 
1   
2 many people have the same feature 
3   
4 few people have the same feature 
5   
6 no one else has the same feature (or the extent of the problem in others is not as 
severe) 
 
2. How frequently during the past four weeks have you checked out your appearance feature (for 
example, looked at it, felt it, measured it in some way) in order to evaluate the extent of the 
problem? 
0 (0 days) no checking 
1 (1-3 days) 
2 (4-7 days) checking once or twice a week 
3 (8-11 days) 
4 (12-16 days) checking on about half the days 
5 (17-21 days) 
6 (22-28 days) checking every or almost every day 
 
3. How dissatisfied have you been with your appearance feature? 
0 no dissatisfaction 
1   
2 slight dissatisfaction (but no feelings of distress) 
3   
4 moderate dissatisfaction (with some feelings of distress) 
5   
6 extreme dissatisfaction (with extreme distress; could not imagine feeling more upset 
or dissatisfied) 
 
4. How dissatisfied have you been with your overall appearance? 
0 no dissatisfaction 
1   
2 slight dissatisfaction (but no feelings of distress) 
3   
4 moderate dissatisfaction (with some feelings of distress) 
5   
6 extreme dissatisfaction (with extreme distress; can’t imagine feeling more 
dissatisfied) 
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5. How frequently have you tried to get reassurance from someone that your appearance feature isn’t 
as bad or abnormal as you think it is? 
0 (0 days) never sought reassurance  
1 (1-3 days) 
2 (4-7 days) sought reassurance once or twice a week 
3 (8-11 days) 
4 (12-16 days) sought reassurance on about half the days 
5 (17-21 days) 
6 (22-28 days) sought reassurance every or almost every day 
 
6. How often have you thought about your appearance feature AND felt upset as a result? 
0 (0 days) never think about the appearance feature with upset feelings 
1 (1-3 days) 
2 (4-7 days) think about it and feel upset once or twice a week 
3 (8-11 days)  
4 (12-16 days) think about it and feel upset on about half the days 
5 (17-21 days) 
6 (22-28 days) think about it and feel upset every or almost every day 
 
7. How much have you worried or felt embarrassed about your appearance feature when you were in 
public areas such as shopping malls, grocery stores, city streets, restaurants, movies, clubs, buses 
or planes, waiting in lines, parks or beaches, public restrooms, or other areas where mainly there 
were people you didn’t know? (When answering, think about how many of these situations you 
worry in and how intense your worrying is.) 
0 no worrying or embarrassment 
1   
2 slight amount of worrying or embarrassment 
3   
4 moderate amount of worrying or embarrassment 
5   
6 extreme worrying or embarrassment 
 
8. How much have you worried or felt embarrassed about your appearance feature when you were in 
social settings with co-workers, acquaintances, friends, family, or family members (for example, 
at work, parties, family gatherings, meetings, talking in groups, having a conversation, dating, or 
going on an outing with others, speaking to a boss or supervisor)? 
0 no worrying or embarrassment 
1   
2 slight amount of worrying or embarrassment 
3   
4 moderate amount of worrying or embarrassment 
5   
6 extreme worrying or embarrassment 
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9. a) How often have you felt that other people were noticing or paying attention to your appearance 
feature? (Include times when you realize you might be imagining it.) 
0 (0 days) never occurred 
1 (1-3 days) 
2 (4-7 days) occurred once or twice a week 
3 (8-11 days) 
4 (12-16 days) occurred on about half the days 
5 (17-21 days) 
6 (22-28 days) occurred every or almost every day 
b) How upset have you become when you felt someone was noticing or paying attention to your 
appearance feature? (When answering, think about whether you feel differently depending on who 
the person is that notices.) 
0 not upsetting (or others do not notice) 
1 slightly upsetting when certain people are involved, but not others 
2 slightly upsetting regardless of who is involved 
3 moderately upsetting when certain people are involved, but not others 
4 moderately upsetting regardless of who is involved 
5 extremely upsetting when certain people are involved, but not others 
6 extremely upsetting regardless of who is involved 
 
 
10. a) How often has someone unexpectedly made a positive or negative comment on your appearance 
feature? (Only include comments that came from “out of the blue,” not comments you might have 
tried to get from the person.) 
0 (0 days) never occurred 
1 (1-3 days) 
2 (4-7 days) occurred once or twice a week 
3 (8-11 days) 
4 (12-16 days) occurred on about half the days 
5 (17-21 days) 
6 (22-28 days) occurred every or almost every day 
b) How upset have you become when someone commented – positively or negatively – on your 
appearance feature? (When answering, think about whether you feel differently depending on who 
the person is that made the comment.) 
0 not upsetting (or others did not comment) 
1 slightly upsetting when certain people commented, but not others 
2 slightly upsetting regardless of who commented 
3 moderately upsetting when certain people commented, but not others 
4 moderately upsetting regardless of who commented 
5 extremely upsetting when certain people commented, but not others 
6 extremely upsetting regardless of who commented 
 
11. a) How often has someone done something to you or for you, that you think is a result of your 
appearance feature? 
0 (0 days) never occurred 
1 (1-3 days) 
2 (4-7 days) occurred once or twice a week 
3 (8-11 days) 
4 (12-16 days) occurred on about half the days 
5 (17-21 days) 
6 (22-28 days) occurred every or almost every day 
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b) How upset have you become when someone has done something to you or for you because of 
your appearance feature? (When answering, think about whether you feel differently depending on 
who the person is that made the comment.) 
0 not upsetting (or others did not treat me differently) 
1 slightly upsetting when certain people were involved, but not others 
2 slightly upsetting regardless of who was involved 
3 moderately upsetting when certain people were involved, but not others 
4 moderately upsetting regardless of who was involved 
5 extremely upsetting when certain people were involved, but not others 
6 extremely upsetting regardless of who was involved 
 
12. How important has appearance been in how you evaluate yourself as a person?  Before answering, 
think about other things that influence how you judge yourself – such as personality, intelligence, 
work or school performance, quality of your relationships with others, ability in other areas, and 
so on.  Compared to these (and maybe others), how much importance have you given to 
appearance when evaluating yourself? 
0 no importance 
1   
2 some importance (definitely an aspect of self-evaluation) 
3   
4 moderate importance (one of the main aspects of self-evaluation) 
5   
6 extreme importance (nothing is more important as a means of evaluating yourself) 
 
13. How negatively have you thought of yourself as a person as a result of your appearance feature?  
This question is not asking whether you think your appearance is attractive or unattractive.  
Rather, it is asking how much your appearance made you feel that you had a personal flaw or were 
undesirable or inadequate in a non-physical way. 
0 no negative evaluations of yourself resulting from your appearance feature 
1   
2 slightly negative evaluations of yourself 
3   
4 moderately negative evaluations of yourself 
5   
6 extremely negative evaluations of yourself; the appearance feature makes you unable 
to find positive qualities in yourself 
 
14. How negatively (if at all) have you felt other people evaluated you as a person as a result of your 
appearance feature?  Again, this question is not asking how attractive or unattractive other people 
think you are.  Rather, it is asking how much you think your appearance made other people see 
you as undesirable or inadequate in some non-physical way. 
0 no negative evaluations by others resulting from your appearance feature 
1   
2 slightly negative evaluations by others 
3   
4 moderately negative evaluations by others 
5   
6 extremely negative evaluations by others; the appearance feature makes others 
unable to find positive qualities in you 
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15. How attractive physically do you feel other people thought you were? (If friends view you 
differently than strangers, how attractive on average do you feel people think you are?) 
0 attractive, or at least not unattractive 
1   
2 slightly unattractive 
3   
4 moderately unattractive 
5   
6 extremely unattractive 
 
16. a) Have you ever thought your appearance feature might not be as bad as you generally think or 
have there been times that you’ve felt significantly better about your appearance feature? 
Yes_______  No_______ 
b) Have you ever felt during the past month that your appearance is basically normal? 
  Yes_______  No_______ 
 
17. How much have you avoided public areas because you felt uncomfortable about your appearance 
feature?  (Such areas might include shopping malls, grocery stores, city streets, restaurants, 
movies, clubs, buses or planes, waiting in lines, parks or beaches, public restrooms, or other areas 
where mainly there would be people you don’t know.) 
0 no avoidance of public situations 
1   
2 avoided with slight frequency 
3   
4 avoided with moderate frequency 
5   
6 avoided with extreme frequency 
 
18. How much have you avoided work or other social situations with friends, relatives, or 
acquaintances because you felt uncomfortable about your appearance feature?  Social situations 
could include going to work or school, parties, family gatherings, meetings, talking in groups, 
having a conversation, hanging out with others, or speaking to a boss or supervisor. 
0 no avoidance of social situations 
1   
2 avoided with slight frequency 
3   
4 avoided with moderate frequency 
5   
6 avoided with extreme frequency 
 
19. How much have you avoided close contact with others because of your appearance feature?  This 
includes sexual activity as well as close contact such as shaking hands, hugging, kissing, or 
dancing close. 
0 no avoidance of physical contact 
1   
2 avoided with slight frequency 
3   
4 avoided with moderate frequency 
5   
6 avoided with extreme frequency 
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20. When making contact physically with others (for example, lovemaking, hugging, shaking hands, 
kissing, dancing close), how often have you tried to restrict the amount of actual contact that 
occurs (for example, by changing your posture, limiting your movement, or preventing contact 
with certain body parts)? 
0 never deliberately restricted physical contact 
1   
2 restricted on less than half the physical contact occasions 
3   
4 restricted on about half the physical contact occasions 
5   
6 restricted on every or almost every physical contact occasion 
 
21. How much have you avoided physical activities such as exercise or outdoor recreation because of 
feeling self-conscious or uncomfortable due to your appearance feature? 
0 no avoidance of physical activity 
1   
2 avoided with slight frequency 
3   
4 avoided with moderate frequency 
5   
6 avoided with extreme frequency 
 
22. How much have you deliberately dressed, made yourself up, or groomed yourself in some special 
way in order to cover up your appearance feature or to distract attention from it?  (This can include 
avoiding certain clothes or cosmetics).  This is called “camouflaging.” 
0 (0 days) never camouflaged or avoided certain clothes/cosmetics 
1 (1-3 days) 
2 (4-7 days) camouflaged one or twice a week 
3 (8-11 days) 
4 (12-16 days) camouflaged on about half the days 
5 (17-21 days) 
6 (22-28 days) camouflaged every or almost every day 
 
23. How frequently have you deliberately changed your posture or body movements (such as the way 
you stand or sit, where you put your hands, how you walk, what side of yourself to show to other 
people, etc.) in order to hide your appearance feature or distract people’s attention from it? 
0 (0 days) no changing of posture or body movements 
1 (1-3 days) 
2 (4-7 days) changed once or twice a week 
3 (8-11 days)  
4 (12-16 days) changed on about half the days 
5 (17-21 days) 
6 (22-28 days) changed every or almost every day 
 
24. How often have you avoided looking at your body, particularly at your appearance feature, in 
order to control feelings about your appearance?  This includes avoiding looking at yourself 
clothed or unclothed either directly or in mirrors or windows. 
0 (0 days) never avoided looking at body 
1 (1-3 days)  
2 (4-7 days) avoided once or twice a week 
3 (8-11 days) 
4 (12-16 days) avoided on about half the days 
5 (17-21 days) 
6 (22-28 days) avoided every or almost every day 
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25. How frequently have you avoided other people seeing your body unclothed because you felt 
uncomfortable about your appearance feature?  This includes not letting your spouse, partner, 
roommate, etc. see you without clothes, or people in public settings such as in health clubs 
showers or changing rooms. 
0 no avoidance of others seeing my body unclothed 
1   
2 avoided with slight frequency 
3   
4 avoided with moderate frequency 
5   
6 avoided with extreme frequency 
 
26. How often have you compared your appearance with the appearance of other people around you or 
in magazines or on television?  Include both positive and negative comparisons. 
0 (0 days) no comparing with others 
1 (1-3 days) 
2 (4-7 days) compared once or twice a week 
3 (8-11 days) 
4 (12-16 days) compared on about half the days 
5 (17-21 days) 
6 (22-28 days) compared every or almost every day 
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APPENDIX E: Multi-Dimensional Body Self Relations Questionnaire – Appearance 
Scales (MBSRQ-AS; Cash, Winstead, & Janda, 1986; Brown, Cash, & Mikulka, 
1990) 
 
 
INSTRUCTIONS – PLEASE READ CAREFULLY 
 
The following pages contain a series of statements about how people might think, feel, or behave.  You are 
asked to indicate the extent to which each statement pertains to you personally.  Your answers to the items 
in the questionnaire are anonymous, so please do not write your name on any of the materials.  In order to 
complete the questionnaire, read each statement carefully and decide how much it pertains to you 
personally.  Using a scale like the one below, indicate your answer by entering it to the left of the number 
of the statement. 
EXAMPLE: 
_____ I am usually in a good mood. 
 
In the blank space,  enter a 1 if you definitely disagree with the statement; 
   enter a 2 if you mostly disagree; 
   enter a 3 if you neither disagree nor agree; 
   enter a 4 if you mostly agree; 
   or enter a 5 if you definitely agree with the statement. 
 
There are no right or wrong answer.  Just give the answer that is most accurate for you.  Remember, your 
responses are confidential, so please be completely honest and answer all items. 
 
 1  2  3  4  5 
     Definitely         Mostly   Neither Agree       Mostly     Definitely 
      Disagree       Disagree    Nor Disagree        Agree         Agree 
 
_____ 1.    Before going out in public, I always notice how I look. 
_____ 2.    I am careful to buy clothes that will make me look my best. 
_____ 3.    My body is sexually appealing.  
_____ 4.    I constantly worry about being or becoming fat. 
_____ 5.    I like my looks the way they are. 
_____ 6.    I check my appearance in a mirror whenever I can. 
_____ 7.    Before going out, I usually spend a lot of time getting ready. 
_____ 8.    I am very conscious of even small changes in my weight. 
_____ 9.    Most people would consider me good-looking. 
_____ 10.  It is important that I always look good. 
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_____ 11.  I use few grooming products. 
_____ 12.  I like the way I look without my clothes on. 
_____ 13.  I am self-conscious if my grooming isn’t right. 
_____ 14.  I usually wear whatever is handy without caring how it looks. 
_____ 15.  I like the way my clothes fit me. 
_____ 16.  I don’t care what people think about my appearance. 
_____ 17.  I take special care with my hair grooming. 
_____ 18.  I dislike my physique.   
_____ 19.  I am physically unattractive. 
_____ 20.  I never think about my appearance. 
_____ 21.  I am always trying to improve my physical appearance. 
_____ 22.  I am on a weight-loss diet. 
 
For the remainder of the items, use the response scale given with the item, and enter your answer in 
the space beside the item. 
 
_____ 23.  I have tried to lose weight by fasting or going on crash diets. 
1. Never 
2. Rarely 
3. Sometimes 
4. Often 
5. Very Often 
 
_____ 24.  I think I am: 
1. Very Underweight 
2. Somewhat Underweight 
3. Normal Weight 
4. Somewhat Overweight 
5. Very Overweight 
 
_____ 25.  From looking at me, most other people would think I am: 
1. Very Underweight 
2. Somewhat Underweight 
3. Normal Weight 
4. Somewhat Overweight 
5. Very Overweight 
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26 – 34.  Use this 1 to 5 scale to indicate how dissatisfied or satisfied you are with each of the following 
areas of your body. 
 
 1  2  3  4  5 
        Very       Mostly        Neither                  Mostly          Very 
  Dissatisfied   Dissatisfied    Satisfied Nor           Satisfied       Satisfied 
        Dissatisfied 
 
 
_____ 26.  Face (facial features, complexion) 
_____ 27.  Hair (color, thickness, texture) 
_____ 28.  Lower torso (buttocks, hips, thighs, legs) 
_____ 29.  Mid torso (waist, stomach) 
_____ 30.  Upper torso (chest or breasts, shoulders, arms) 
_____ 31.  Muscle tone 
_____ 32.  Weight 
_____ 33.  Height 
_____ 34.  Overall Appearance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX F: Beck Depression Inventory – II 
(BDI-II; Beck, Steer, & Brown, 1996) 
 
 
MATERIAL REMOVED AT REQUEST OF HARCOURT ASSESSMENT, THE 
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